<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pre‐emptive correction for haemodialysis arteriovenous access stenosis - Ravani, P - 2016 | Cochrane Library</title> <meta content="Pre‐emptive correction for haemodialysis arteriovenous access stenosis - Ravani, P - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010709.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pre‐emptive correction for haemodialysis arteriovenous access stenosis - Ravani, P - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010709.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010709.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pre‐emptive correction for haemodialysis arteriovenous access stenosis" name="citation_title"/> <meta content="Pietro Ravani" name="citation_author"/> <meta content="Cumming School of Medicine, University of Calgary" name="citation_author_institution"/> <meta content="pravani@ucalgary.ca" name="citation_author_email"/> <meta content="Robert R Quinn" name="citation_author"/> <meta content="Cumming School of Medicine, University of Calgary" name="citation_author_institution"/> <meta content="Matthew J Oliver" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Divya J Karsanji" name="citation_author"/> <meta content="Cumming School of Medicine, University of Calgary" name="citation_author_institution"/> <meta content="Matthew T James" name="citation_author"/> <meta content="Cumming School of Medicine, University of Calgary" name="citation_author_institution"/> <meta content="Jennifer M MacRae" name="citation_author"/> <meta content="Cumming School of Medicine, University of Calgary" name="citation_author_institution"/> <meta content="Suetonia C Palmer" name="citation_author"/> <meta content="University of Otago Christchurch" name="citation_author_institution"/> <meta content="Giovanni FM Strippoli" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD010709.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/01/07" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010709.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010709.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010709.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Arteriovenous Shunt, Surgical [adverse effects]; *Renal Dialysis; Constriction, Pathologic [diagnosis, prevention &amp; control]; Kidney Failure, Chronic [*therapy]; Primary Prevention; Randomized Controlled Trials as Topic; Secondary Prevention; Thrombosis [diagnosis]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010709.pub2&amp;doi=10.1002/14651858.CD010709.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="urvLIhM4";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010709\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010709\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010709.pub2",title:"Pre\\u2010emptive correction for haemodialysis arteriovenous access stenosis",firstPublishedDate:"Jan 7, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010709.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010709.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010709.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010709.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010709.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010709.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010709.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010709.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010709.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010709.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1980 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010709.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0083"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0050"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/appendices#CD010709-sec-0088"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/table_n/CD010709StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/table_n/CD010709StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pre‐emptive correction for haemodialysis arteriovenous access stenosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Pietro Ravani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0003">Robert R Quinn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0004">Matthew J Oliver</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0005">Divya J Karsanji</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0006">Matthew T James</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0007">Jennifer M MacRae</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0008">Suetonia C Palmer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information#CD010709-cr-0009">Giovanni FM Strippoli</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information/en#CD010709-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 07 January 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010709.pub2">https://doi.org/10.1002/14651858.CD010709.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010709-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010709-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010709-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010709-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010709-abs-0001" lang="en"> <section id="CD010709-sec-0001"> <h3 class="title" id="CD010709-sec-0001">Background</h3> <p>Guidelines recommend routine arteriovenous (AV) graft and fistula surveillance (technology‐based screening) in addition to clinical monitoring (physical examination) for early identification and pre‐emptive correction of a stenosis before the access becomes dysfunctional. However, consequences on patient‐relevant outcomes of pre‐emptive correction of a stenosis in a functioning access as opposed to deferred correction, i.e. correction postponed to when the access becomes dysfunctional, are uncertain. </p> </section> <section id="CD010709-sec-0002"> <h3 class="title" id="CD010709-sec-0002">Objectives</h3> <p>We aimed to evaluate 1) whether pre‐emptive correction of an AV access stenosis improves clinically relevant outcomes; 2) whether the effects of pre‐emptive correction of an AV access stenosis differ by access type (fistula versus graft), aim (primary and secondary prophylaxis), and surveillance method for primary prophylaxis (Doppler ultrasound for the screening of functional and anatomical changes versus measurement of the flow in the access); and 3) whether other factors (dialysis duration, access location, configuration or materials, algorithm for referral for intervention, intervention strategies (surgical versus radiological or other), or study design) explain the heterogeneity that might exist in the effect estimates. </p> </section> <section id="CD010709-sec-0003"> <h3 class="title" id="CD010709-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Specialised Register to 30 November 2015 using search terms relevant to this review. </p> </section> <section id="CD010709-sec-0004"> <h3 class="title" id="CD010709-sec-0004">Selection criteria</h3> <p>We included all studies of any access surveillance method for early identification and pre‐emptive treatment of an AV access stenosis. </p> </section> <section id="CD010709-sec-0005"> <h3 class="title" id="CD010709-sec-0005">Data collection and analysis</h3> <p>We extracted data on potentially remediable and irremediable failure of the access (i.e. thrombosis and access loss respectively); infection and mortality; and resource use (hospitalisation, diagnostic and intervention procedures). Analysis was by a random effects model and results expressed as risk ratio (RR), hazard ratio (HR) or incidence rate ratio (IRR) with 95% confidence intervals (CI). </p> </section> <section id="CD010709-sec-0006"> <h3 class="title" id="CD010709-sec-0006">Main results</h3> <p>We identified 14 studies (1390 participants), nine enrolled adults without a known access stenosis (primary prophylaxis; three studies including people using fistulas) and five enrolled adults with a documented stenosis in a non‐dysfunctional access (secondary prophylaxis; three studies in people using fistulas). Study follow‐up ranged from 6 to 38 months, and study size ranged from 58 to 189 participants. In low‐ to moderate‐quality evidence (based on GRADE criteria) in adults treated with haemodialysis, relative to no surveillance and deferred correction, surveillance with pre‐emptive correction of an AV stenosis reduced the risk of thrombosis (RR 0.79, 95% CI 0.65 to 0.97; I² = 30%; 18 study comparisons, 1212 participants), and probably improves the longevity of AV access (RR 0.80, 95% CI 0.64 to 0.99; I² = 0%; 11 study comparisons, 972 participants). In analyses subgrouped by access type, pre‐emptive stenosis correction did not reduce the risk of thrombosis (RR 0.95, 95% CI 0.8 to 1.12; I² = 0%; 11 study comparisons, 697 participants) or access loss in grafts (RR 0.87, 95% CI 0.69 to 1.11; I² = 0%; 7 study comparisons; 662 participants), but did reduce the risk of thrombosis (RR 0.5, 95% CI 0.35 to 0.71; I² = 0%; 7 study comparisons, 515 participants) and the risk of access loss in fistulas (RR 0.5, 95% CI 0.29 to 0.86; I² = 0%; 4 studies; 310 participants). Three of the four studies reporting access loss data in fistulas (199 participants) were conducted in the same centre. Insufficient data were available to assess whether benefits vary by prophylaxis aim in fistulas (i.e. primary and secondary prophylaxis). Although the magnitude of the effects of pre‐emptive stenosis correction was considerable for patient‐centred outcomes, results were either heterogeneous or imprecise. While pre‐emptive stenosis correction may reduce the rates of hospitalisation (IRR 0.54, 95% CI 0.31 to 0.93; I² = 67%; 4 study comparisons, 219 participants) and use of catheters (IRR 0.58, 95% CI 0.35 to 0.98; I² = 53%; 6 study comparisons, 394 participants), it may also increase the rates of diagnostic procedures (IRR 1.78, 95% CI 1.18 to 2.67; I² = 62%; 7 study comparisons, 539 participants), infection (IRR 1.74, 95% CI 0.78 to 3.91; I² = 0%; 3 studies, 248 participants) and mortality (RR 1.38, 95% CI 0.91 to 2.11; I² = 0%; 5 studies, 386 participants). </p> <p>In general, risk of bias was high or unclear in most studies for many domains we assessed. Four studies were published after 2005 and only one had evidence of registration within a trial registry. No study reported information on authorship and/or involvement of the study sponsor in data collection, analysis, and interpretation. </p> </section> <section id="CD010709-sec-0007"> <h3 class="title" id="CD010709-sec-0007">Authors' conclusions</h3> <p>Pre‐emptive correction of a newly identified or known stenosis in a functional AV access does not improve access longevity. Although pre‐emptive stenosis correction may be promising in fistulas existing evidence is insufficient to guide clinical practice and health policy. While pre‐emptive stenosis correction may reduce the risk of hospitalisation, this benefit is uncertain whereas there may be a substantial increase (i.e. 80%) in the use of access‐related procedures and procedure‐related adverse events (e.g. infection, mortality). The net effects of pre‐emptive correction on harms and resource use are thus unclear. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010709-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010709-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010709-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010709-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010709-abs-0003">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010709-abs-0002" lang="en"> <h3>Pre‐emptive correction of stenosis of the arteriovenous access for haemodialysis</h3> <p>An arteriovenous access consists of a direct surgical connection between an artery and a vein in the arm (fistula) or a plastic conduit connecting an artery and a vein (graft). If these forms of access become dysfunctional the delivery of dialysis therapy becomes suboptimal. The most common cause of access dysfunction is the development of a restriction or conduit narrowing called 'stenosis'. Because early correction of stenosis is considered critical to maintain the patency (openness) of the access and prolong its use, guidelines recommend regular surveillance of the access (i.e. screening based on diagnostic tests) in addition to or instead of a physical exam (clinical monitoring) to identify and treat early lesions. </p> <p>In this review we included 14 studies, randomising 1390 participants to either a pre‐emptive correction of an access stenosis (i.e. before the access became dysfunctional) or a deferred correction of an access stenosis (i.e. if and when the access became dysfunctional). This review shows that pre‐emptive correction of an arteriovenous access stenosis does not improve longevity of the access overall. In people using grafts pre‐emptive correction does not reduce the risk of thrombosis or access loss. In people using fistulas pre‐emptive stenosis correction reduces the risk of thrombosis and may prolong the longevity of the access. However, this surveillance and pre‐emptive correction strategy may increase the number of access‐related procedures and procedure‐related adverse events. </p> <p>This systematic review presents, to clinicians and patients, evidence‐based data that do not support the use of access surveillance and pre‐emptive correction of stenosis in grafts. Although surveillance and pre‐emptive correction of stenosis reduce the risk of thrombosis and may reduce the risk of access loss in fistulas, they may also increase the risk of procedure‐related adverse events and health‐care cost. Large multicentre clinical trials are necessary in this patient population to better clarify potential harms and expected benefits of routine surveillance and pre‐emptive correction of fistula stenosis. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010709-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010709-sec-0083"></div> <h3 class="title" id="CD010709-sec-0084">Implications for practice</h3> <section id="CD010709-sec-0084"> <p>Our review does not support the use of pre‐emptive correction of stenosis in grafts and casts doubts upon the use of pre‐emptive correction of stenosis in fistulas. While available evidence shows that pre‐emptive correction of a stenosis reduces the risk of thrombosis in fistulas, which in turn may result in prolonged fistula longevity, data on access loss (the most important outcome) are based on low‐ to moderate‐quality evidence from only three small single‐centre studies conducted in the same centre and reported by the same investigators. Although pre‐emptive correction of fistula stenosis may be more effective in secondary prophylaxis, data supporting this practice come from these same studies. Until more research is available any prevention strategy should be weighed against potential harms of this practice (increased number of invasive procedures, procedure‐related adverse events) and resource use. Considering the potential harms and inconvenience associated with these procedures, patients’ involvement in decision‐making is key to determine the management strategy that is more consistent with their preferences and values. </p> </section> <h3 class="title" id="CD010709-sec-0085">Implications for research</h3> <section id="CD010709-sec-0085"> <p>Considering the lack of benefits of pre‐emptive correction of stenosis in graft, different questions need to be addressed in this area, including development of new vascular materials to reduce the risk of complications, interventions to prevent stenosis or reduce the risk of restenosis after a salvage procedure. </p> <p>Conversely, considering the possible benefits of pre‐emptive correction of an established stenosis in functioning fistulas, a large RCT with fistula loss as main outcome is warranted. Such secondary prophylaxis RCT must include also patient outcomes (QoL, infections and mortality) and data on resource use and cost as secondary outcomes (including staff time for access screening and data collection and interpretation). Based on the findings of our review we estimated (based on a log‐rank test) that an RCT of 1020 participants per arm recruited over one year and followed for three years (480 total events) will have a power of 90% to detect as significant at the two‐sided P value of 0.01 at least a 30% reduction in the HR for access loss, assuming a baseline risk of 10% per year and a withdrawal rate of 10%. Numbers are smaller (about 800/group) assuming an exponential model for time to event. </p> <p>To better inform clinical practice in this area, and promote patient‐centred care, data on patient preferences and views about expected benefits and potential harms of access surveillance and pre‐emptive correction of access stenosis should be included in future research. These data will allow development of decision aids and incorporation of patient perspectives and informed decisions into a truly shared decision‐making process at the bedside. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010709-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010709-sec-0015"></div> <div class="table" id="CD010709-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Scheduled surveillance versus clinical monitoring alone for preventing arteriovenous (AV) access failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Scheduled surveillance versus clinical monitoring alone for the prevention of AV access failure (maintenance of suitability for haemodialysis in an established AV access)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis. </p> <p>Settings: inpatient, outpatient or home care setting</p> <p>Intervention: Surveillance of the access with Doppler ultrasound or blood flow measurements with or without clinical monitoring of the access. </p> <p>Comparison: clinical monitoring alone, i.e. physical examination with or without haemodynamic parameters measured during haemodialysis (e.g. pump blood flow, arterial and venous pressure) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Monitoring alone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Surveillance in addition to monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Risk of access thrombosis</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Higher risk population (people using a graft for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR</b> 0.95 (0.8, 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>697 (11 cohorts from 8 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Most studies are small with low‐quality reporting</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>475 per 1000</b> <br/> (400 to 560) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Lower risk population (people using a fistula for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 0.5 (0.35, 0.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>515 (7 cohorts from 6 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>400 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/> (140 to 284) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Rate of angiograms</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>People using any AV access (fistula or graft)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 1.78 (1.18, 2.67) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>539 (7 cohorts from 5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>300 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>534 per 1000</b> </p> <p>(354 to 801)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Baseline risks and rates (among controls ‐ people receiving clinical monitoring without surveillance) were calculated from the survival plots or information the papers reported. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010709-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Scheduled surveillance versus clinical monitoring alone for the prevention of arteriovenous (AV) access failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Scheduled surveillance versus clinical monitoring alone for the prevention of AV access failure (maintenance of suitability for haemodialysis in an established AV access)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis. </p> <p>Settings: inpatient, outpatient or home care setting.</p> <p>Intervention: Surveillance of the access with Doppler ultrasound or blood flow measurements with or without clinical monitoring of the access. </p> <p>Comparison: clinical monitoring alone, i.e. physical examination with or without haemodynamic parameters measured during haemodialysis (e.g. pump blood flow, arterial and venous pressure) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Monitoring alone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Surveillance in addition to monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Risk of access loss</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Higher risk population (people using a graft for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR</b> 0.90 (0.71, 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>662 (7 cohorts from 6 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Most studies are small with low‐quality reporting</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>135 per 1000</b> <br/> (107 to 172) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Lower risk population (people using a fistula for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 0.5 (0.29, 0.86) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>310 (4 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (29 to 86) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Mortality</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>People using any AV access (fistula or graft)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 1.38 (0.90, 2.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>586 (5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>207 per 1000</b> </p> <p>(135 to 317)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Baseline risks and rates (among controls ‐ people receiving clinical monitoring without surveillance) were calculated from the survival plots or information the papers reported. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010709-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010709-sec-0016"></div> <p>Haemodialysis, the most common treatment for kidney failure globally, requires reliable access to the bloodstream by means of a vascular access. The native arteriovenous (AV) fistula and the AV graft are considered the best types of access (<a href="./references#CD010709-bbs2-0064" title="AllonM , RobbinML . Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Con. Journal of the American Society of Nephrology2008;19(9):1632‐3. [MEDLINE: 18754117] ">Allon 2008</a>; <a href="./references#CD010709-bbs2-0065" title="BesarabA . Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro. Journal of the American Society of Nephrology2008;19(9):1629‐31. [MEDLINE: 18508963] ">Besarab 2008</a>) because large observational studies have shown that their use is associated with better patient outcomes than central venous catheters (<a href="./references#CD010709-bbs2-0068" title="DhingraRK , YoungEW , Hulbert‐ShearonTE , LeaveySF , PortFK . Type of vascular access and mortality in U.S. hemodialysis patients. Kidney International2001;60(4):1443‐51. [MEDLINE: 11576358] ">Dhingra 2001</a>; <a href="./references#CD010709-bbs2-0078" title="PastanS , SoucieJM , McClellanWM . Vascular access and increased risk of death among hemodialysis patients. Kidney International2002;62(2):620‐6. [MEDLINE: 12110026] ">Pastan 2002</a>). This belief was reinforced by a recent meta‐analysis that showed that people using catheters had the highest risk of death from all causes, infection and cardiovascular disease (<a href="./references#CD010709-bbs2-0080" title="RavaniP , PalmerSC , OliverMJ , QuinnRR , MacRaeJM , TaiDJ , et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. Journal of the American Society of Nephrology2013;24(3):465‐73. [MEDLINE: 23431075] ">Ravani 2013a</a>). </p> <section id="CD010709-sec-0017"> <h3 class="title" id="CD010709-sec-0017">Description of the condition</h3> <p>AV fistulas and grafts consist of a direct surgical connection between an artery and a vein (fistula), or a bridge conduit between an artery and a vein (graft), usually made of synthetic material. Remodelling of blood vessels after AV access creation results in access maturation (enlargement) and increased blood flow, which permits haemodialysis (<a href="./references#CD010709-bbs2-0082" title="Roy‐ChaudhuryP , SukhatmeVP , CheungAK . Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. Journal of the American Society of Nephrology2006;17(4):1112‐27. [MEDLINE: 16565259] ">Roy‐Chaudhury 2006</a>). However, scarring and abnormal remodelling may also contribute to access stenosis, dysfunction and thrombosis, a leading cause of hospitalisation in haemodialysis patients (<a href="./references#CD010709-bbs2-0075" title="MannsB , TonelliM , YilmazS , LeeH , LauplandK , KlarenbachS , et al. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. Journal of the American Society of Nephrology2005;16(1):201‐9. [MEDLINE: 15563567] ">Manns 2005</a>). While early inflow complications within the first few months after access creation are more common in fistulas than in grafts (<a href="./references#CD010709-bbs2-0067" title="DemberLM , BeckGJ , AllonM , DelmezJA , DixonBS , GreenbergA , et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA2008;299(18):2164‐71. [MEDLINE: 18477783] ">Dember 2008</a>), late complications of an established and functioning access are more common in grafts, and include venous outflow, graft‐vein, graft‐artery and intra‐graft lesions in grafts, and outflow and inflow lesions in fistulas (<a href="./references#CD010709-bbs2-0082" title="Roy‐ChaudhuryP , SukhatmeVP , CheungAK . Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. Journal of the American Society of Nephrology2006;17(4):1112‐27. [MEDLINE: 16565259] ">Roy‐Chaudhury 2006</a>). Additional procedures are performed in 80% of newly‐created fistulas to salvage access function (1.45 to 3.3 procedures/access‐year, three times higher than in grafts), with an overall cost to facilitate fistula maturation (CAD 7740 in the first year) similar to that of a successful graft creation (CAD 8130 in the first year) (<a href="./references#CD010709-bbs2-0074" title="LokCE . Fistula first initiative: advantages and pitfalls. Clinical Journal of the American Society of Nephrology: CJASN2007;2(5):1043‐53. [MEDLINE: 17702726] ">Lok 2007</a>). About half of the fistulas that mature without additional interventions (20% of all fistulas) require some revisions in the long‐term (0.17 to 0.57 procedures/access‐year) (<a href="./references#CD010709-bbs2-0074" title="LokCE . Fistula first initiative: advantages and pitfalls. Clinical Journal of the American Society of Nephrology: CJASN2007;2(5):1043‐53. [MEDLINE: 17702726] ">Lok 2007</a>). Since these rates are six times lower than in grafts in the long‐term, fistulas are considered the most cost‐effective haemodialysis access (USD 4862/year) (<a href="./references#CD010709-bbs2-0065" title="BesarabA . Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro. Journal of the American Society of Nephrology2008;19(9):1629‐31. [MEDLINE: 18508963] ">Besarab 2008</a>). </p> </section> <section id="CD010709-sec-0018"> <h3 class="title" id="CD010709-sec-0018">Description of the intervention</h3> <p>In most haemodialysis programs, different screening methods are routinely used for early identification of a haemodynamically significant AV access stenosis (<a href="./references#CD010709-bbs2-0076" title="Vascular Access Work Group. Clinical practice guidelines for vascular access. American Journal of Kidney Diseases2006;48 Suppl 1:S248‐73. [MEDLINE: 16813991] ">National Kidney Foundation 2006</a>). These screening methods consist of physical examination (monitoring) and technology‐based strategies (surveillance). Clinical monitoring includes examination of the access thrill and bruit, haemostasis time after needle removal and arm assessment. Haemodialysis parameters such as pump speed, and arterial and transmembrane pressure, and indices of dialysis adequacy (Kt/V or urea reduction ratio (URR)) are also part of clinical monitoring. Surveillance includes sequential measurements with trend analysis of intra‐access flow, dynamic or static venous dialysis pressure (venous pressure to systolic blood pressure ratio), or duplex ultrasound. </p> </section> <section id="CD010709-sec-0019"> <h3 class="title" id="CD010709-sec-0019">How the intervention might work</h3> <p>In the presence of a trend toward critical values of these indices, guidelines recommend patient referral for an imaging study and, if a stenotic lesion is diagnosed, pre‐emptive correction of stenoses greater than 50% is recommended to prevent further progression of vessel narrowing and thrombosis of the access (<a href="./references#CD010709-bbs2-0072" title="JindalK , ChanCT , DezielC , HirschD , SorokaSD , TonelliM , et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. Journal of the American Society of Nephrology2006;17(3 Suppl 1):S1‐27. [MEDLINE: 16497879] ">Jindal 2006</a>; <a href="./references#CD010709-bbs2-0076" title="Vascular Access Work Group. Clinical practice guidelines for vascular access. American Journal of Kidney Diseases2006;48 Suppl 1:S248‐73. [MEDLINE: 16813991] ">National Kidney Foundation 2006</a>; <a href="./references#CD010709-bbs2-0079" title="PolkinghorneK , Caring for Australians with Renal Impairment(CARI) . The CARI guidelines. Vascular access surveillance. Nephrology2008;13 Suppl 2:S1‐11. [MEDLINE: 18713118] ">Polkinghorne 2008</a>; <a href="./references#CD010709-bbs2-0084" title="TordoirJ , CanaudB , HaageP , KonnerK , BasciA , FouqueD , et al. EBPG on vascular access. Nephrology Dialysis Transplantation2007;22 Suppl 2:ii88‐117. [MEDLINE: 17507428] ">Tordoir 2007</a>; <a href="./references#CD010709-bbs2-0081" title="Renal Association. Vascular Access for Haemodialysis. www.renal.org/guidelines/modules/vascular‐access‐for‐haemodialysis#sthash.CTWNC6Ue.dpbs (accessed 23 November 2015). ">Renal Association 2015</a>). These pre‐emptive radiological intervention procedures (angioplasty with or without stenting) or surgical corrections of a stenosis in a functioning access are expected to prevent thrombosis of the access, improve its suitability for dialysis, increase dialysis dose delivery and increase the longevity of the AV access with reduced long‐term access‐related procedures and cost, compared to deferred salvage interventions performed only if and when the access becomes dysfunctional. However, the evidence in support of such practice is controversial (<a href="./references#CD010709-bbs2-0083" title="TonelliM , JamesM , WiebeN , JindalK , HemmelgarnB , Alberta Kidney Disease Network. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. American Journal of Kidney Diseases2008;51(4):630‐40. [MEDLINE: 18371539] ">Tonelli 2008</a>). In addition, information regarding access loss, costs, and hospitalisation rates following implementation of these screening strategies (a measure of potential harm and use of health care resources) is scarce. </p> </section> <section id="CD010709-sec-0020"> <h3 class="title" id="CD010709-sec-0020">Why it is important to do this review</h3> <p>Current guidelines recommend routine surveillance of permanent AV accesses (<a href="./references#CD010709-bbs2-0076" title="Vascular Access Work Group. Clinical practice guidelines for vascular access. American Journal of Kidney Diseases2006;48 Suppl 1:S248‐73. [MEDLINE: 16813991] ">National Kidney Foundation 2006</a>; <a href="./references#CD010709-bbs2-0081" title="Renal Association. Vascular Access for Haemodialysis. www.renal.org/guidelines/modules/vascular‐access‐for‐haemodialysis#sthash.CTWNC6Ue.dpbs (accessed 23 November 2015). ">Renal Association 2015</a>), but several studies and a systematic review (<a href="./references#CD010709-bbs2-0083" title="TonelliM , JamesM , WiebeN , JindalK , HemmelgarnB , Alberta Kidney Disease Network. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. American Journal of Kidney Diseases2008;51(4):630‐40. [MEDLINE: 18371539] ">Tonelli 2008</a>) have been published since these guidelines were last updated. Given the considerable morbidity associated with access dysfunction, but also the important resource implications and unclear benefits and harms of these screening strategies, knowledge synthesis about optimal ways to improve outcomes of a functioning access is a priority for patients, clinicians and health policy makers. In this systematic review we have summarised data from randomised controlled trials (RCTs) on the benefits and harms of pre‐emptive correction of AV access stenosis on the risk of major vascular access and patient‐centred endpoints. We conducted this systematic review and meta‐analysis of RCTs according to a published peer‐reviewed protocol (<a href="./references#CD010709-bbs2-0085" title="RavaniP , JamesMT , MacRaeJM , PalmerSC , QuinnRR , OliverMJ , et al. Pre‐emptive correction for haemodialysis arteriovenous access stenosis. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD010709] ">Ravani 2013b</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010709-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010709-sec-0021"></div> <p> <ol id="CD010709-list-0001"> <li> <p>To evaluate whether pre‐emptive correction of an AV access stenosis improves clinically relevant outcomes </p> <ol id="CD010709-list-0002"> <li> <p>Access outcomes: risk of thrombosis (potentially remediable unsuitability for haemodialysis) and access abandonment (irremediable access loss) </p> </li> <li> <p>Patient outcomes: infection rates and mortality; surrogate outcomes (measures of heart function and structure, of access flow, and of haemodialysis adequacy) </p> </li> <li> <p>Resource use: rates of diagnostic and intervention procedures to maintain access patency, and of hospitalisation. </p> </li> </ol> </li> <li> <p>To evaluate whether the effects of pre‐emptive correction of an AV access stenosis differ by access type (fistula versus graft); aim (primary and secondary prophylaxis); and surveillance method for primary prophylaxis (Doppler ultrasound for the screening of functional and anatomical changes versus measurement of the flow in the access) </p> </li> <li> <p>To evaluate whether other factors (dialysis duration, access location, configuration or materials, algorithm for referral for intervention, intervention strategies (surgical versus radiological or other), or study design) explain the heterogeneity that might exist in the effect estimates. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010709-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010709-sec-0022"></div> <section id="CD010709-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010709-sec-0024"> <h4 class="title">Types of studies</h4> <p>We included RCTs and quasi‐RCTs (RCTs in which allocation to treatment was obtained by predictable methods such as alternation, use of alternate medical records, or date of birth) evaluating the benefits and harms of a pre‐emptive strategy to correct AV access stenosis in adults treated with haemodialysis or planned to start haemodialysis for end‐stage kidney disease. We included studies of any follow‐up duration without language restriction. </p> </section> <section id="CD010709-sec-0025"> <h4 class="title">Types of participants</h4> <section id="CD010709-sec-0026"> <h5 class="title">Inclusion criteria</h5> <p>We included RCTs that enrolled people who had an AV access (either a fistula or a graft) that was suitable for haemodialysis (or other extra‐corporeal dialysis methods including haemofiltration and haemodiafiltration) regardless of the duration of their dialysis treatment. We included RCTs of pre‐emptive stenosis correction in a mature AV access. These studies evaluated the effects of strategies planned to identify (through regular access surveillance) and correct pre‐emptively a previously unknown/unidentified access stenosis (primary prophylaxis) or the effects of pre‐emptive correction of a known stenosis in a non‐dysfunctional access (secondary prophylaxis). </p> </section> <section id="CD010709-sec-0027"> <h5 class="title">Exclusion criteria</h5> <p>We excluded studies in which participants received haemodialysis to treat acute kidney injury or used a central venous catheter for haemodialysis instead of an AV access. We also excluded studies comparing different approaches to salvage a dysfunctional, failing or clotted access (an access that was not suitable for haemodialysis). </p> </section> </section> <section id="CD010709-sec-0028"> <h4 class="title">Types of interventions</h4> <section id="CD010709-sec-0029"> <h5 class="title">Active interventions</h5> <p>Interventions could be based on a surveillance method (alone or in addition to standard clinical monitoring) designed to identify early stenotic lesions in a functioning AV access that could be corrected pre‐emptively, i.e. prior to access dysfunction (primary prophylaxis). Any screening strategy and diagnostic criteria defining the access eligibility for correction were allowed, including surveillance techniques and imaging tests, or a critical value for a documented stenosis or a lesion clinically suspected. Also, any pre‐emptive correction procedure was allowed including surgical interventions (open or endovascular surgery) or imaging‐assisted procedures (angioplasty), with or without stenting. In studies enrolling people with a documented stenotic lesion in an otherwise functioning AV fistula or graft the active intervention was any of these pre‐emptive correction procedures (secondary prophylaxis). </p> </section> <section id="CD010709-sec-0030"> <h5 class="title">Comparator</h5> <p>The comparator was either another surveillance method for pre‐emptive correction of an access stenosis (active comparator) or a strategy based on deferred correction of a stenosis, i.e. a correction postponed to when the access became dysfunctional (inactive comparator). As for the intervention, for the comparator we considered any diagnostic criteria for eligibility for correction, including monitoring methods, surveillance techniques and imaging tests, or a critical value for a documented stenosis or a lesion clinically suspected. </p> </section> </section> <section id="CD010709-sec-0031"> <h4 class="title">Types of outcome measures</h4> <p>We considered access outcomes (primary outcomes) and outcomes related to the patient and the health care system (secondary outcomes). </p> <section id="CD010709-sec-0032"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was the achievement of long‐term access suitability for cannulation and use for haemodialysis (longevity of the access or long‐term patency). Two events could reduce access patency: a potentially remediable access failure (thrombosis or imminent thrombosis ‐ an intermediate outcome) and an irremediable access failure (leading to access abandonment or loss ‐ the most important outcome). Depending on whether the event affecting access survival was the initial problem of the access or the final access‐terminating event we defined patency rates as follows. </p> <p> <ul id="CD010709-list-0003"> <li> <p>Primary (unassisted) patency: the event of interest was the first cause of dysfunction (i.e. thrombosis or imminent thrombosis), which could be remediable or irremediable, or the first intervention required to salvage the access (regardless of whether it was successful or unsuccessful). </p> </li> <li> <p>Secondary (assisted) patency: the event of interest is the final (irremediable) access failure, leading to abandonment of the access (i.e. access loss), regardless of previous procedures performed to prolong the life of the access up to that point. </p> </li> </ul> </p> <p>We captured these events considering the information reported on access suitability, i.e. the ability to successfully use the AV access as defined in the included studies (<a href="./references#CD010709-bbs2-0073" title="LokCE , AllonM , MoistL , OliverMJ , ShahH , ZimmermanD . Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). Journal of the American Society of Nephrology2006;17(11):3204‐12. [MEDLINE: 16988062] ">Lok 2006</a>). </p> </section> <section id="CD010709-sec-0033"> <h5 class="title">Secondary outcomes</h5> <p>Secondary access‐level outcomes</p> <p> <ul id="CD010709-list-0004"> <li> <p>Need for access evaluation defined as a formal clinical assessment or diagnostic imaging study, and intervention required to achieve maturation, maintain function, or correct dysfunction of an AV access, or as defined in the included studies </p> </li> <li> <p>Surgical interventions on the AV access defined as a vascular access procedure to maintain function, or correct dysfunction of an AV access, or as defined in the included studies </p> </li> <li> <p>Diagnostic or interventional radiological procedures on the access defined as a fistulogram or angioplasty of an AV access, or as defined in the included studies </p> </li> <li> <p>Any access complications (including infection, aneurysm, high flow and steal syndrome), as defined in the included studies. </p> </li> </ul> </p> <p>Secondary patient‐level and system‐level outcomes</p> <p> <ul id="CD010709-list-0005"> <li> <p>All‐cause mortality</p> </li> <li> <p>Cause‐specific mortality (from infection or cardiovascular disease as evaluated in the included studies) </p> </li> <li> <p>Non‐fatal cardiovascular events</p> <ul id="CD010709-list-0006"> <li> <p>Myocardial infarction or acute coronary syndrome as defined in the included studies</p> </li> <li> <p>Cerebrovascular accident of transient Ischaemic attack as defined in the included studies </p> </li> <li> <p>Exacerbation of heart failure as defined in the included studies</p> </li> <li> <p>Ventricular arrhythmia or sudden death or cardiac conduction disorder as defined in the included studies. </p> </li> </ul> </li> <li> <p>All‐cause hospitalisation and hospitalisation for any specific cause defined as admission to a hospital for any reason or as defined in the included studies </p> </li> <li> <p>Quality of life measured with the SF‐36 scale or any kidney disease specific quality of life tool or any other measure provided in the included studies </p> </li> </ul> </p> <p>We planned to capture the following surrogate outcomes</p> <p> <ul id="CD010709-list-0007"> <li> <p>Measurements of heart function and structure used to predict patient outcomes including left ventricular (LV) hypertrophy, LV mass index, LV systolic ejection fraction, and LV end diastolic dimension determined using any technique or threshold as defined in the included studies. </p> </li> <li> <p>Measurements of access function including access blood flow, dynamic or static venous pressure monitoring using the techniques and thresholds to determine dysfunction as defined in the included studies. </p> </li> <li> <p>Adequate dialysis dose delivery defined as a URR &gt; 70%, single‐pool Kt/V ≥ 1.2, or any other measure of dialysis adequacy as defined in the included studies. </p> </li> </ul> </p> </section> </section> </section> <section id="CD010709-sec-0034"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010709-sec-0035"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Kidney and Transplant Specialised Register (to 30 November 2015) using search terms relevant to this review. The Specialised Register contains studies identified from the following sources. </p> <p> <ol id="CD010709-list-0008"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of renal‐related journals and the proceedings of major nephrology conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected nephrology journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>We identified studies contained in the Specialised Register through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of the Cochrane Kidney and Transplant. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD010709-sec-0089">Appendix 1</a> for search strategies. </p> </section> <section id="CD010709-sec-0036"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD010709-list-0009"> <li> <p>Reference lists of clinical practice guidelines, review articles and relevant studies.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> <li> <p>Information from the authors (see <a href="#CD010709-sec-0086">Acknowledgements</a>). </p> </li> </ol> </p> </section> </section> <section id="CD010709-sec-0037"> <h3 class="title" id="CD010709-sec-0037">Data collection and analysis</h3> <section id="CD010709-sec-0038"> <h4 class="title">Selection of studies</h4> <p>Two authors independently screened the search results by title and abstract, then full text, to identify potentially eligible studies that fulfilled the inclusion criteria. Any study considered potentially eligible by at least one reviewer was retrieved for further review. We considered all RCTs of any AV access screening method or pre‐emptive stenosis correction that reported data for adults receiving or planned to receive haemodialysis to treat kidney failure. </p> </section> <section id="CD010709-sec-0039"> <h4 class="title">Data extraction and management</h4> <p>Two authors independently extracted data for population characteristics, interventions, non‐randomised co‐interventions, and risk of bias into a purpose‐built database. Each author double‐checked data extraction and data entry independently, and any discrepancies between authors were resolved by discussion. Where more than one publication of one study existed, we grouped the reports together. </p> </section> <section id="CD010709-sec-0040"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors independently evaluated the following risk‐of‐bias items using the Cochrane risk of bias assessment tool (<a href="./references#CD010709-bbs2-0071" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (see <a href="./appendices#CD010709-sec-0090">Appendix 2</a>). </p> <p> <ul id="CD010709-list-0010"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was the analysis done according to the intention‐to‐treat principle (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD010709-list-0011"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (selection and attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> <p>For the latter item we considered failure to report a study hypothesis or assumptions of sample size estimation, unequal co‐interventions, early termination of a study with failure to report pre‐specified stopping rules, industry sponsor as author or involved in data handling and analysis, and flaws in data analysis. We also recorded whether studies reported information on registration in the primary study report. </p> </section> <section id="CD010709-sec-0041"> <h4 class="title">Measures of treatment effect</h4> <p>We extracted data on all access‐level, patient‐level and system‐level outcomes. To incorporate expected study‐to‐study variability beyond what would be expected by chance, analysis was by a random effects model. As all outcomes were dichotomous, results were expressed as risk ratio (RR), hazard ratio (HR) or incidence rate ratio (IRR) with 95% confidence intervals (CI). </p> </section> <section id="CD010709-sec-0042"> <h4 class="title">Unit of analysis issues</h4> <p>In access‐level outcome analyses the unit of analysis was the access. For patient‐ and system‐level outcomes the unit of analysis was the patient. </p> </section> <section id="CD010709-sec-0043"> <h4 class="title">Dealing with missing data</h4> <p>Where only proportions of participants experiencing an event were provided in the study report (rather than raw event data), we estimated the number of participants experiencing one or more events by multiplying the proportion affected by the sample size, and contacted the study authors for additional information. When not reported, we calculated rates of a binary event as the ratio of the event number and the reported average follow‐up. For incomplete survival data reporting (i.e. available survival plots or life table data but lack of a HR estimate), we obtained the estimate of the HR using the method by <a href="./references#CD010709-bbs2-0077" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints.[Erratum appears in Stat Med. 2004 Jun 15;23(11):1817]. Statistics in Medicine1998;17(24):2815–34. [MEDLINE: 9921604] ">Parmar 1998</a>. We assumed a Poisson distribution for count data to calculate the variance of the log‐IRR (when a measure of precision was not reported). We included all relevant studies in the systematic review and included in the meta‐analysis the data that they reported (<a href="./references#CD010709-bbs2-0071" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010709-sec-0044"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed for heterogeneity in summary effects using the Cochran Q and the I² test (with 95% CI), with P value of 0.1 used for statistical significance (<a href="./references#CD010709-bbs2-0070" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). We considered I² values of 0% to 25%, 26% to 50%, 51 to 75% and ≥ 76% indicating respectively low, moderate, considerable and substantial levels of heterogeneity. </p> </section> <section id="CD010709-sec-0045"> <h4 class="title">Assessment of reporting biases</h4> <p>We used funnel plots of the log‐RR in individual studies against their standard error to search for asymmetry but did not formally test for asymmetry or quantify the possible effect of any publication bias due to the low number of studies (<a href="./references#CD010709-bbs2-0071" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010709-sec-0046"> <h4 class="title">Data synthesis</h4> <p>We used the random‐effects model for data synthesis, because of important differences between studies in terms of design, participants, interventions and co‐interventions. For all analyses, a two‐tailed P value &lt; 0.05 indicated statistical significance. We conducted the analyses using R statistical software (R Foundation for Statistical Computing; <a href="http://www.R-project.org" target="_blank">www.R‐project.org</a>) and RevMan. Because three studies compared the effects of different interventions with the same comparator arm (<a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>) we split the comparator arm of these studies in meta‐analyses. </p> </section> <section id="CD010709-sec-0047"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were aware that several factors were potentially responsible for heterogeneity including study population characteristics, publication year, gender, diabetes, presence of cardiovascular disease, age, time on dialysis, haemodialysis technique (including haemofiltration and haemodiafiltration) and anatomical location of the access, material, AV access configuration, or diagnostic criteria or type of intervention (angioplasty or surgery). However, due to the low number of studies, and to avoid inflation of the type I error rate (<a href="./references#CD010709-bbs2-0070" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>), we conducted subgroup analyses according to the following pre‐specified characteristics: type of access (fistula and graft); aim of the intervention (primary and secondary prophylaxis); and type of intervention (ultrasound‐based surveillance, which provides both functional and anatomical information about the access, and access flow‐measurement‐based or access pressure‐measurement‐based surveillance, which provide only functional data). We did not study the impact of bias on heterogeneity. We considered moderate heterogeneity or higher (I² &gt; 25%) as measure of support for separate data reporting by subgroup. </p> </section> <section id="CD010709-sec-0048"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses by including and excluding studies according to the following criteria. </p> <p> <ul id="CD010709-list-0012"> <li> <p>Participants assigned to the comparator arm received an additional screening (i.e. measurement of dynamic or static pressure in addition to clinical monitoring) </p> </li> <li> <p>Participants assigned to the intervention arm received an additional screening (i.e. measurement of dynamic or static pressure in addition to Doppler ultrasound or flow measurement) </p> </li> <li> <p>Participants assigned to the comparator arm did not receive clinical monitoring</p> </li> <li> <p>Participants assigned to the intervention arm did not receive clinical monitoring</p> </li> <li> <p>HR calculated from the survival curves (as opposed to reported by authors).</p> </li> </ul> </p> <p>We also compared meta‐analyses of RR and HR for the same outcome.</p> <p>Because the DerSimonian‐Laird (DL) procedure is considered unstable with small numbers of studies, in sensitivity analyses we confirmed results using a restricted maximum likelihood (REML) method (equivalent to iterated Der‐Simonian Laird) (<a href="./references#CD010709-bbs2-0066" title="CornellJE , MulrowCD , LocalioR , StackCB , MeibohmAR , GuallarE , et al. Random‐effects meta‐analysis of inconsistent effects: a time for change. Annals of Internal Medicine2014;160(4):267‐70. [MEDLINE: 24727843] ">Cornell 2014</a>). We also used methods that incorporate in the variance estimation the uncertainty related to residual heterogeneity (Knapp‐Hartung method). To account for potential correlation of effect estimates from the same study we used methods that account for potential correlation in the data (robust variance correction and mixed modelling). Finally we checked consistency of findings by summarizing binary events using a binomial approximation of the likelihood which may be preferred in relatively small studies. </p> <section id="CD010709-sec-0049"> <h5 class="title">Grading of Recommendations Assessment, Development and Evaluation (GRADE)</h5> <p>We summarised the quality of the evidence, together with absolute treatment effects based on estimated baseline risks, using GRADE guidelines (<a href="./references#CD010709-bbs2-0069" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924–6. [MEDLINE: 18436948] ">Guyatt 2008</a>). According to this system the evidence from RCTs is initially graded as high, but is downgraded in the presence of bias in the studies, inconsistency in the direction or magnitude of study findings, indirectness related to differences in populations, interventions or outcomes between studies and the clinical context, imprecision of the estimated effects and publication bias. GRADE conceptualises the evidence quality as follows: high quality—further research is very unlikely to change our confidence in the estimate of effect; moderate quality—further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; low quality—further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; very low quality—any estimate of effect is very uncertain. To estimate the absolute number of people using a fistula or a graft for haemodialysis who avoided a clotting event or incurred in an access procedure, the risk estimate and 95% CI were obtained from corresponding meta‐analyses, together with the absolute population risk derived from data in the control groups of the included studies. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010709-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010709-sec-0050"></div> <section id="CD010709-sec-0051"> <h3 class="title">Description of studies</h3> <section id="CD010709-sec-0052"> <h4 class="title">Results of the search</h4> <p>Our search of the Specialised Register identified 110 reports. After initial screening of the titles and abstracts 18 reports were excluded (not randomised, wrong population or intervention). The remaining 91 reports were assessed and we included 14 studies (30 reports) (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>) and excluded 35 (50 reports) (<a href="./references#CD010709-bbs2-0023" title="AftabSA , TayKH , IraniFG , Gong LoRH , GognaA , HaalandB , et al. Randomized clinical trial of cutting balloon angioplasty versus high‐pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. Journal of Vascular &amp; Interventional Radiology2014;25(2):190‐8. [MEDLINE: 24315548] ">Aftab 2014</a>; <a href="./references#CD010709-bbs2-0024" title="BacchiniG , PalmierL , CappelloA , LaMiliaV , AndrulliS , FrigerioC , et al. Prospective randomized study evaluating the effectiveness of brachitherapy in the prevention of re‐stenosis of vascular access after balloon angioplasty ‐ preliminary results [abstract no: 50]. Blood Purification2003;21(6):446. [CENTRAL: CN‐00508953] BacchiniG , PalmieriL , GapelloA , LaMiliaV , AndrulliS , FrigerioC , et al. Prospective randomized study evaluating the effectiveness of brachitherapy in the prevention of re‐stenosis of vascular access after balloon angioplasty: preliminary results [abstract]. Nephrology Dialysis Transplantation2003;18(Suppl 4):735. [CENTRAL: CN‐00444288] ">Bacchini 2003</a>; <a href="./references#CD010709-bbs2-0025" title="BeathardGA . Gianturco self‐expanding stent in the treatment of stenosis in dialysis access grafts. Kidney International1993;43(4):872‐7. [MEDLINE: 8479123] ">Beathard 1993</a>; <a href="./references#CD010709-bbs2-0026" title="BeathardGA . Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts. Kidney International1994;45(5):1401‐6. [MEDLINE: 8072252] BeathardGA . Mechanical vs pharmacomechanical thrombolysis for clotted dialysis access grafts [abstract no: 9P]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):333. [MEDLINE: CN‐00483161] ">Beathard 1994</a>; <a href="./references#CD010709-bbs2-0027" title="Roy‐ChaudhuryP , ArnoldP , SeigelJ , MisraS . From basic biology to randomized clinical trial: The Beta Radiation for ArterioVenous Graft Outflow Stenosis (BRAVO II). Seminars in Dialysis2013;26(2):227‐32. [MEDLINE: 23067015] Roy‐ChaudhuryP , MishraS , LynchPM , BRAVO Study Investigators. Endovascular radiation therapy for hemodiaylsis vascular access stenosis (the BRAVO study) [abstract]. Nephrology Dialysis Transplantation2003;18(Suppl 4):734. [CENTRAL: CN‐00447485] Roy‐ChaudhuryP , MisraS , BRAVO II Study Investigators. BRAVO II, a multicenter randomized study of endovascular radiation therapy for thrombosed PTFE dialysis grafts: study design and protocol [abstract no: SA‐PO952]. Journal of the American Society of Nephrology2003;14(Nov):508A. [CENTRAL: CN‐00583321] Roy‐ChaudhuryP , MisraS , BRAVO II Study Investigators. Efficacy and safety of brachytherapy in PTFE graft stenosis [abstract no: F‐PO747]. Journal of the American Society of Nephrology2006;17(Abstracts):495A. [CENTRAL: CN‐00601948] ">BRAVO II Study 2013</a>; <a href="./references#CD010709-bbs2-0028" title="MisraS , BonanR , PfledererT , Roy‐ChaudhuryP , BRAVO I Investigators. BRAVO I: a pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney International2006;70(11):2006‐13. [MEDLINE: 17035947] Roy‐ChaudhuryP , MisraS , BRAVO I Study Investigators. BRAVO I: A pilot study of endovascular radiation therapy for PTFE dialysis grafts [abstract no: SA‐PO951]. Journal of the American Society of Nephrology2003;14(Nov):508A. [CENTRAL: CN‐00583322] Roy‐ChaudhuryP , ZuckermanD , DuncanH , FoleyJ , MisraS . Endovascular radiation therapy reduces venous stenosis in PTFE dialysis access grafts [abstract no: SU‐FC081]. Journal of the American Society of Nephrology2004;15(Oct):61A. [CENTRAL: CN‐00583653] ">BRAVO I Study 2006</a>; <a href="./references#CD010709-bbs2-0029" title="BrooksJL , SigleyRD , MayKJJr , MackRM . Transluminal angioplasty versus surgical repair for stenosis of hemodialysis grafts. A randomized study. American Journal of Surgery1987;153(6):530‐1. [MEDLINE: 2954477] ">Brooks 1987</a>; <a href="./references#CD010709-bbs2-0030" title="CohenGS , FreemanH , RingoldMA , PutnamSG , BallDS , SilvermanC , et al. External beam irradiation as an adjunctive treatment in failing dialysis shunts. Journal of Vascular &amp; Interventional Radiology2000;11(3):321‐6. [MEDLINE: 10735426] ">Cohen 2000</a>; <a href="./references#CD010709-bbs2-0031" title="DoughertyMJ , CalligaroKD , SchindlerN , RaviolaCA , NtosoA . Endovascular versus surgical treatment for thrombosed hemodialysis grafts: a prospective, randomized study. Journal of Vascular Surgery1999;30(6):1016‐23. [MEDLINE: 10587385] ">Dougherty 1999</a>; <a href="./references#CD010709-bbs2-0032" title="ForauerAR , HofferEK , HomaK . Dialysis access venous stenoses: treatment with balloon angioplasty‐‐1‐ versus 3‐minute inflation times. Radiology2008;249(1):375‐81. [MEDLINE: 18796688] ">Forauer 2008</a>; <a href="./references#CD010709-bbs2-0033" title="Roy‐ChaudhuryP , The Mercator Study Investigators. Perivascular dexamethasone for PTFE graft stenosis: The HAPPI (Hemodialysis Access Patency extension with Percutaneous transluminal Infusion of dexamethasone) study [abstract no: SA‐PO579]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):468A‐9A. ">HAPPI Study 2007</a>; <a href="./references#CD010709-bbs2-0034" title="HaskalZ , ScottS , BermanMD . Results of the U.S. Multi‐center, randomized trial of the Bard ePTFE encapsulated stent graft versus balloon angioplasty in patients with failing dialysis AV access grafts [abstract]. Peripheral Vascular Surgical Society (PVSS) Spring Meeting; 2005 Jun 16–19; Chicago (Ill). 2005. [CENTRAL: CN‐00550268] HaskalZJ , MietlingS , TrerotolaS , BermanS , VeselyT , AltmanS , et al. Stent grafts prolong dialysis graft patency: results of the U.S. multicenter randomized trial of the Bard e‐PTFE encapsulated stent graft versus balloon angioplasty. Cardiovascular and Interventional Radiological Society of Europe Conference; 2005 Sep 10‐14; Nice, France. 2005. [CENTRAL: CN‐00671831] HaskalZJ , SchumanE , AltmanS , TrerotolaS , BermanS . PTFE stent grafts improve dialysis access graft patency: results of the U.S. randomized multicenter trial [abstract no: TH‐FC044]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00677760] HaskalZJ , TrerotolaS , DolmatchB , SchumanE , AltmanS , MietlingS , et al. Stent graft versus balloon angioplasty for failing dialysis‐access grafts. New England Journal of Medicine2010;362(6):494‐503. [MEDLINE: 20147715] HaskalZJ , TrerotolaS , DolmatchB , et al. Stent graft versus balloon angioplasty for failing dialysis‐access grafts [abstract]. Journal of Vascular Surgery2010;51(5):1322. ">Haskal 2010</a>; <a href="./references#CD010709-bbs2-0035" title="HaskalZ . 24‐month final results from the RENOVA study: A randomized controlled comparison of stent grafts and balloon angioplasty for dialysis access graft preservation [abstract]. Journal of Vascular &amp; Interventional Radiology2014;25(3 Suppl 1):S6. [EMBASE: 71381043] HaskalZJ . Twelve month results of the RENOVA trial: A prospective multicenter randomized, concurrently‐controlled comparison of the Flair endovascular stent graft vs. balloon angioplasty in dialysis access grafts [abstract]. Journal of Vascular &amp; Interventional Radiology2013;24(4 Suppl 1):S5. [EMBASE: 71039902] ">Haskal 2013</a>; <a href="./references#CD010709-bbs2-0036" title="HegabSE , ElemamA , LotfyH , KotbH . Salvage of occluded native AVF: surgical thrombectomy versus percutaneous endovenous thromboaspiration [abstract]. Journal of Vascular &amp; Interventional Radiology2013;24(4 Suppl 1):S111. [EMBASE: 71040135] ">Hegab 2013</a>; <a href="./references#CD010709-bbs2-0037" title="HofferEK , SultanS , HerskowitzMM , DanielsID , SclafaniSJ . Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. Journal of Vascular &amp; Interventional Radiology1997;8(6):965‐73. [MEDLINE: 9399465] ">Hoffer 1997</a>; <a href="./references#CD010709-bbs2-0038" title="KatsanosK , KarnabatidisD , KitrouP , SpiliopoulosS , ChristeasN , SiablisD . Paclitaxel‐coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6‐month interim results from a prospective randomized controlled trial. Journal of Endovascular Therapy2012;19(2):263‐72. [MEDLINE: 22545894] KatsanosK , KitrouPM , KarnabatidisD , SpiliopoulosS , DiamantopoulosA , SiablisD . Paclitaxel‐coated balloon angioplasty versus plain balloon dilatation for the treatment of failing dialysis access: A prospective randomized controlled trial [abstract]. Journal of Vascular &amp; Interventional Radiology2012;23(8):1109. [EMBASE: 71415469] KatsanosKN , KitrouPM , SpiliopoulosS , DiamantopoulosA , KarnabatidisD , SiablisD . Paclitaxel‐coated balloon angioplasty versus plain balloon dilatation for the treatment of failing dialysis access: a prospective randomized controlled trial [abstract]. Cardiovascular &amp; Interventional Radiology2012;35:S154. [CENTRAL: CN‐00840900] KitrouPM , KatsanosKN , DiamantopoulosA , SpiliopoulosS , ChristeasN , KarnabatidisD , et al. Paclitaxel‐eluting balloon angioplasty versus plain balloon dilatation for the treatment of failing dialysis access: a prospective randomized controlled trial (NCT01174472) [abstract no: 1307.3]. Cardiovascular &amp; Interventional Radiology2011;34(3 Suppl):503. [EMBASE: 70624121] KitrouPM , SpiliopoulosS , ChristeasN , DiamantopoulosA , SiablisD , KarnabatidisD . Paclitaxel‐coated balloons as a treatment option of arterio‐venous fistula stenosis: 1‐year final results of a prospective randomized controlled trial [abstract]. Journal of Vascular &amp; Interventional Radiology2014;25(3 Suppl 1):S9. [EMBASE: 71381047] ">Katsanos 2012</a>; <a href="./references#CD010709-bbs2-0039" title="KhooLS , TayKH , LoR , TanejaM , LinSE , TeoT , et al. Prospective, randomised controlled trial of cutting balloon angioplasty (CBA) versus high pressure balloon angioplasty (HPBA) in hemodialysis arterio‐venous graft (AVG) and arterio‐venous fistula (AVF) stenosis resistant to conventional percutaneous transluminal angioplasty (PTA): a preliminary report [abstract]. Cardiovascular &amp; Interventional Radiology2010;33(Suppl 2):222. [EMBASE: 70288985] ">Khoo 2010</a>; <a href="./references#CD010709-bbs2-0040" title="KunduS , ClemensR , AzizaJ , TamP , NagaiG , YouJ , et al. Ultrahigh‐pressure angioplasty versus the Peripheral Cutting BalloonTM for treatment of stenoses in autogenous fistulas: comparison of immediate results. Journal of Vascular Access2010;11(4):303‐11. [MEDLINE: 20658454] ">Kundu 2010</a>; <a href="./references#CD010709-bbs2-0041" title='GrayR . Regarding "Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts". Journal of Vascular Surgery1998;27(2):392‐3. [MEDLINE: 9510303] KumpeDA . Regarding "Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts". Journal of Vascular Surgery1998;28(2):386‐7. [MEDLINE: 9719343] MarstonWA , CriadoE , JaquesPF , MauroMA , BurnhamSJ , KeagyBA . Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts. Journal of Vascular Surgery1997;26(3):373‐80. [MEDLINE: 9308583] '>Marston 1997</a>; <a href="./references#CD010709-bbs2-0042" title="MiddlebrookMR , AmygdalosMA , SoulenMC , HaskalZJ , Shlansky‐GoldbergRD , CopeC , et al. Thrombosed hemodialysis grafts: percutaneous mechanical balloon declotting versus thrombolysis. Radiology1995;196(1):73‐7. [MEDLINE: 7784593] ">Middlebrook 1995</a>; <a href="./references#CD010709-bbs2-0043" title="OnoT , GotoH , MorishitaK , KondoH , HirakataH , IidaM . Immediate hemodialysis after percutaneous transvenous angioplasty increases patency rates of arterio‐venous fistula. Clinical Nephrology2004;62(4):301‐5. [MEDLINE: 15524061] ">Ono 2004</a>; <a href="./references#CD010709-bbs2-0044" title="QuinnSF , SchumanES , DemlowTA , StandageBA , RagsdaleJW , GreenGS , et al. Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: intermediate results. Journal of Vascular &amp; Interventional Radiology1995;6(6):851‐5. [MEDLINE: 8850659] ">Quinn 1995</a>; <a href="./references#CD010709-bbs2-0045" title="DuncanH , NarayanaA , ZuckermandD , AlspaughJ , VuD , KantS , et al. External radiation therapy for hemodialysis vascular access occlusion [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):287A. [CENTRAL: CN‐00445166] Roy‐ChaudhuryP , DuncanHJ , ZuckermanD , FaiyazR , MundaR , KantS , et al. External beam radiation therapy for PTFE dialysis grafts: a pilot study. Journal of Vascular Access2012;13(3):329‐31. [MEDLINE: 22287221] ">Roy‐Chaudhury 2012</a>; <a href="./references#CD010709-bbs2-0046" title="SainiA , MillerC , AhmedI , AhmadF , SalterR , SandhuC . Randomised controlled trial comparing the efficacy of high pressure balloon angioplasty (HPBA) versus peripheral cutting balloon angioplasty (PCBA) for the treatment of venous stenoses in native arteriovenous dialysis fistulae (AVF): preliminary results [abstract]. Cardiovascular &amp; Interventional Radiology2008;31(Suppl 3):339. ">Saini 2008</a>; <a href="./references#CD010709-bbs2-0047" title="SchumanE , QuinnS , StandageB , GrossG . Thrombolysis versus thrombectomy for occluded hemodialysis grafts. American Journal of Surgery1994;167(5):473‐6. [MEDLINE: 8185029] ">Schuman 1994</a>; <a href="./references#CD010709-bbs2-0048" title="SheleyRC , SchumanES , StandageBA , RagsdaleJW , FelicianoPD , QuinnSF . Local delivery of heparin with balloon angioplasty: results of a prospective randomized trial. Journal of Vascular &amp; Interventional Radiology1996;7(6):853‐8. [MEDLINE: 8951752] ">Sheley 1996</a>; <a href="./references#CD010709-bbs2-0049" title="ShemeshD , GoldinI , ZaghalI , BerlowitzD , RavehD , OlshaO . Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: a prospective randomized clinical trial. Journal of Vascular Surgery2008;48(6):1524‐31. [MEDLINE: 18829240] ">Shemesh 2008</a>; <a href="./references#CD010709-bbs2-0050" title="TeoT , TanBS , YinW , LoR , IraniFG , ChoongHS , et al. Prospective randomized trial comparing Drug‐eluting Balloon Versus Conventional Percutaneous Transluminal Angioplasty (DEBAPTA) for the treatment of hemodialysis arteriovenous fistula or arteriovenous graft stenoses ‐ Interim report of first 30 patients [abstract]. Journal of Vascular &amp; Interventional Radiology2013;24(4 Suppl 1):S40‐1. [EMBASE: 71039967] TeoTK , TanBS , YinWH , IraniFG , GognaA , RamamurthyS , et al. Interim analysis of the DEBAPTA trial: A randomized trial comparing drug‐eluting balloon angioplasty versus conventional percutaneous transluminal angioplasty for treatment of hemodialysis arteriovenous fistula or arteriovenous graft stenoses [abstract]. Cardiovascular &amp; Interventional Radiology2013;36:S229. [EMBASE: 71323303] ">Teo 2013</a>; <a href="./references#CD010709-bbs2-0051" title="TessitoreN , LipariG , PoliA , BedognaV , MantovaniW , TessariA , et al. A prospective controlled trial on surgical vs endovascular treatment of stenosis in forearm arteriovenous fistulae (AVF) [abstract no: SU‐FC082]. Journal of the American Society of Nephrology2004;15(Oct):61A. [CENTRAL: CN‐00782283] ">Tessitore 2004b</a>; <a href="./references#CD010709-bbs2-0052" title="UflackerR , RajagopalanPR , VujicI , StutleyJE . Treatment of thrombosed dialysis access grafts: randomized trial of surgical thrombectomy versus mechanical thrombectomy with the Amplatz device. Journal of Vascular &amp; Interventional Radiology1996;7(2):185‐92. [MEDLINE: 9007796] ">Uflacker 1996</a>; <a href="./references#CD010709-bbs2-0053" title="VerouxP , GiaquintaA , TallaritaT , SinagraN , VirgilioC , ZerboD , et al. Primary balloon angioplasty of small (≤ 2 mm) cephalic veins improves primary patency of arteriovenous fistulae and decreases reintervention rates. Journal of Vascular Surgery2013;57(1):131‐6. [MEDLINE: 23153423] ">Veroux 2013</a>; <a href="./references#CD010709-bbs2-0054" title="VeselyTM , IdsoMC , AudrainJ , WindusDW , LowellJA . Thrombolysis versus surgical thrombectomy for the treatment of dialysis graft thrombosis: pilot study comparing costs. Journal of Vascular &amp; Interventional Radiology1996;7(4):507‐12. [MEDLINE: 8855526] ">Vesely 1996</a>; <a href="./references#CD010709-bbs2-0055" title="VeselyTM , WilliamsD , WeissM , StainkenB , MatalonT , DolmatchB . Comparison of the angiojet rheolytic catheter to surgical thrombectomy for the treatment of thrombosed hemodialysis grafts. Peripheral AngioJet Clinical Trial. Journal of Vascular &amp; Interventional Radiology1999;10(9):1195‐1205. [MEDLINE: 10527197] ">Vesely 1999</a>; <a href="./references#CD010709-bbs2-0056" title="VeselyTM , SiegelJB . Use of the peripheral cutting balloon to treat hemodialysis‐related stenoses. Journal of Vascular &amp; Interventional Radiology2005;16(12):1593‐603. [MEDLINE: 16371523] ">Vesely 2005</a>; <a href="./references#CD010709-bbs2-0057" title="WhittierWL , MansyHA , RutzDR , LewisAM , SandlerRH . Comparison of hemodialysis access flow measurements using flow dilution and in‐line dialysance. ASAIO Journal2009;55(4):369‐72. [MEDLINE: 19471158] ">Whittier 2009</a>. In addition there are three ongoing studies (<a href="./references#CD010709-bbs2-0061" title="NCT01200914 . Placement of covered stents to treat hemodialysis access stenosis in the cephalic arch and central veins. clinicaltrials.gov/ct2/show/NCT01200914 (accessed 23 November 2015). ">NCT01200914</a>; <a href="./references#CD010709-bbs2-0062" title="NCT01391975 . A multi centre randomized controlled trial of the clinical and cost effectiveness of duplex ultrasound surveillance with proactive intervention versus no surveillance and reactive intervention for the management of stenosis in arterio‐venous fistulae for dialysis vascular access. clinicaltrials.gov/ct2/show/NCT01391975 (accessed 23 November 2015). ">NCT01391975</a>; <a href="./references#CD010709-bbs2-0063" title="NCT01538108 . The use of NMB drug ejecting balloon for arteriovenous (AV) dialysis fistulae. clinicaltrials.gov/ct2/show/NCT01538108 (accessed 23 November 2015). ">NCT01538108</a>) and two studies have recently been completed but as yet there are no published data (<a href="./references#CD010709-bbs2-0058" title="NCT01001676 . Local delivery of paclitaxel for prevention of restenosis in hemodialysis access. clinicaltrials.gov/ct2/show/NCT01001676 (accessed 23 November 2015). ">NCT01001676</a>; <a href="./references#CD010709-bbs2-0059" title="NCT01544907 . Prospective randomized trial comparing drug eluting balloon angioplasty versus conventional percutaneous transluminal angioplasty balloon for the treatment of hemodialysis arterio‐venous fistula or arterio‐venous graft stenoses. clinicaltrials.gov/ct2/show/NCT01544907 (accessed 23 November 2015). ">NCT01544907</a>) (see <a href="#CD010709-fig-0001">Figure 1</a>). All 14 included studies contributed to qualitative and quantitative synthesis. </p> <div class="figure" id="CD010709-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study selection flow diagram‐PRISMA" data-id="CD010709-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study selection flow diagram‐PRISMA</p> </div> </div> </div> <p>Prior to publication a final search of the Specialised Register identified one new report (<a href="./references#CD010709-bbs2-0060" title="SandsJ , GandyD , FinnM , JohnsonA , BurrowsS , MirandaC . Ultrasound‐angioplasty program decreases thrombosis rate and cost of PTFE graft maintenance [abstract no: A0802]. Journal of the American Society of Nephrology1997;8(Programs &amp; Abstracts):171A. [CENTRAL: CN‐00447574] ">Sands 1997</a>). This will be assessed in a future update of this review. </p> </section> <section id="CD010709-sec-0053"> <h4 class="title">Included studies</h4> <p>We included 14 studies comprising 1390 adult participants in this review, of which nine (1065 participants) enrolled adults without access stenosis (primary prophylaxis; three studies (313 participants) in people using fistulas) and five (325 participants) enrolled adults with a documented stenosis in a functioning access (secondary prophylaxis; three studies (197 participants) in people using fistulas). </p> <p>Detailed information on the design, participants, intervention, comparator and outcomes of the included studies are summarised in <a href="./references#CD010709-sec-0100" title="">Characteristics of included studies</a> and <a href="#CD010709-tbl-0003">Table 1</a>. Nine studies (1065 participants) (<a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>) enrolled people without a suspected or documented stenosis of the access (primary prophylaxis), and five (325 participants) enrolled people with either a documented (<a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>) or suspected (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>) stenosis of a functioning access (secondary prophylaxis). </p> <div class="table" id="CD010709-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Format of reported outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Loss</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Thrombosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Angiography</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> PTA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> SX</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> PTA or SX</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Need for CVC</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Infection</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Hospital admission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Stenosis detection</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Death</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR†; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR^</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR†;HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>PTA indicates angioplasty; SX ‐ surgical intervention; CVC ‐ central venous catheter; RR ‐ relative risk; HR ‐ hazard ratio (time to event data); IRR ‐ incidence rate ratio (from rate data). </p> <p>^Rates and follow‐up reported</p> <p>†Events from survival plots</p> <p>‡Log‐HR (and their standard errors) were not reported by the authors but were estimated from survival plots (or tables) using the methods proposed by <a href="./references#CD010709-bbs2-0077" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints.[Erratum appears in Stat Med. 2004 Jun 15;23(11):1817]. Statistics in Medicine1998;17(24):2815–34. [MEDLINE: 9921604] ">Parmar 1998</a>. </p> </div> </div> <p>In studies of primary prophylaxis pre‐emptive correction of a stenosis followed the identification of the stenosis by means of different surveillance strategies. These strategies involved Doppler ultrasound in at least one of the intervention arms (<a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>), blood flow measurement in at least one of the intervention arms (<a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>) or measures of venous pressure in at least one intervention arm (<a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>). Three studies reported two comparisons each (<a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>). One study compared blood‐flow measurement or static venous pressure and Doppler ultrasound every six months with Doppler ultrasound screening every six months (<a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>). </p> <p>In 11 studies participants in both the intervention and control arms received clinical monitoring (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). In one study of secondary prophylaxis participants were randomised to undergo angiography confirmation and correction of a stenosis (suspected on the basis of an increase in the static venous pressure) or to continue venous pressure monitoring of the access until it became dysfunctional (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>). In the other four studies of secondary prophylaxis participants had an angiography documented stenosis and were randomised to undergo correction or continue clinical monitoring until the access became dysfunctional (<a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). </p> <p>Sample sizes ranged from 58 to 189 participants and the follow‐up from 6 to 38 months. Participants' age in these studies ranged between 55.7 and 64.6 years; the proportion of males ranged between 41% and 68% and the proportion of diabetics ranged between 20% and 61%. Eight studies included only people using a graft (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>), five only people using a fistula (<a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>), and one study included participants with a graft and participants with a fistula (<a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>). </p> </section> <section id="CD010709-sec-0054"> <h4 class="title">Excluded studies</h4> <p>Reasons for exclusion of excluded studies are summarised in <a href="./references#CD010709-sec-0101" title="">Characteristics of excluded studies</a>. Most tested different interventions to correct a stenotic lesion in a dysfunctional access. Four of the five ongoing studies do not address the research question of this review. Information about the fifth study (<a href="./references#CD010709-bbs2-0062" title="NCT01391975 . A multi centre randomized controlled trial of the clinical and cost effectiveness of duplex ultrasound surveillance with proactive intervention versus no surveillance and reactive intervention for the management of stenosis in arterio‐venous fistulae for dialysis vascular access. clinicaltrials.gov/ct2/show/NCT01391975 (accessed 23 November 2015). ">NCT01391975</a>) has not been updated since July 2011. </p> </section> </section> <section id="CD010709-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias is summarised in <a href="#CD010709-fig-0002">Figure 2</a> and <a href="#CD010709-fig-0003">Figure 3</a>. In general, risk of bias was high or unclear in most studies for many domains we assessed. Four studies were published after 2005 (<a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>) and only one had evidence of registration within a trial registry (<a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). No study reported information on authorship and/or involvement of the study sponsor in data collection, analysis, and interpretation. </p> <div class="figure" id="CD010709-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010709-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010709-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010709-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010709-sec-0056"> <h4 class="title">Allocation</h4> <section id="CD010709-sec-0057"> <h5 class="title">Random sequence generation</h5> <p>Six studies were judged to be at low risk of bias (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>) and the remaining eight studies were judged unclear. </p> </section> <section id="CD010709-sec-0058"> <h5 class="title">Allocation concealment</h5> <p>Four studies were judged to be at low risk of bias (<a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>), four studies were at high risk of bias (<a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>), and the remaining six studies were judged unclear. </p> </section> <section id="CD010709-sec-0059"> <h5 class="title">Intention‐to‐treat analysis</h5> <p>Four studies were judged to be at low risk of bias (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>), four studies were at high risk of bias (<a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>), and the remaining six studies were unclear. </p> </section> </section> <section id="CD010709-sec-0060"> <h4 class="title">Blinding</h4> <section id="CD010709-sec-0061"> <h5 class="title">Participants and personnel (performance bias)</h5> <p>Only two studies reported blinding of participants and personnel (<a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>); one only blinded participants (<a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>). Eleven studies were judged to be at high risk of bias (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). </p> </section> <section id="CD010709-sec-0062"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>Only one study reported on blinding of outcome assessors (<a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>). Although thrombosis and access loss are objective outcomes, reporting was unclear for the other 13 studies. </p> </section> </section> <section id="CD010709-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>Five studies were at low risk of attrition bias (<a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a>; <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>), four studies were at high risk of bias (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>) and the remaining studies were judged unclear. </p> </section> <section id="CD010709-sec-0064"> <h4 class="title">Selective reporting</h4> <p>One study was at high risk of bias (<a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>) and the remaining 13 studies were judge to be at low risk of reporting bias. </p> </section> <section id="CD010709-sec-0065"> <h4 class="title">Other potential sources of bias</h4> <p>Eight studies failed to report the study hypothesis or the sample size estimation (<a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a>; <a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a>; <a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a>; <a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a>; <a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>). Two studies were stopped early but failed to report details on the stopping rule (<a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). In one study clinicians were notified about the results of the angiography only for participants of the intervention arm (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>). In three studies the unit of analysis was the access but the methods for handling correlated data were not reported (<a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a>; <a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>). Only one study reported information on registration in a trial registry (<a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). </p> </section> </section> <section id="CD010709-sec-0066"> <h3 class="title" id="CD010709-sec-0066">Effects of interventions</h3> <p>See: <a href="./full#CD010709-tbl-0001"><b>Summary of findings for the main comparison</b> Scheduled surveillance versus clinical monitoring alone for preventing arteriovenous (AV) access failure</a>; <a href="./full#CD010709-tbl-0002"><b>Summary of findings 2</b> Scheduled surveillance versus clinical monitoring alone for the prevention of arteriovenous (AV) access failure</a> </p> <section id="CD010709-sec-0067"> <h4 class="title">Effects on access patency</h4> <section id="CD010709-sec-0068"> <h5 class="title">Assisted patency (access loss)</h5> <p>In the meta‐analysis of all studies (including people with a fistula or graft) we found that pre‐emptive correction of an AV access stenosis probably improves the longevity of AV access (<a href="./references#CD010709-fig-0007" title="">Analysis 1.1</a> (11 study comparisons, 972 participants): RR 0.80, 95% CI 0.63 to 0.99; I² = 0%). Subgroup analyses showed pre‐emptive stenosis correction significantly reduced the risk of access loss in fistulas (<a href="./references#CD010709-fig-0008" title="">Analysis 1.2</a>.1 (4 studies, 310 participants): RR 0.50, 95% CI 0.29 to 0.86; I² = 0%) but not in grafts (<a href="./references#CD010709-fig-0008" title="">Analysis 1.2</a>.2 (7 study comparisons, 662 participants): RR 0.87, 95% CI 0.69 to 1.11; I² = 0%). Three of the four studies reporting access loss data in fistulas (199 participants) were conducted in the same centre and reported by the same authors (<a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). There were no significant subgroup differences by prevention aim (primary and secondary prophylaxis) and surveillance method in primary prophylaxis, and insufficient data for subgroup analysis by prevention aim in fistulas (<a href="./references#CD010709-fig-0009" title="">Analysis 1.3</a>; <a href="./references#CD010709-fig-0010" title="">Analysis 1.4</a>; <a href="./references#CD010709-fig-0011" title="">Analysis 1.5</a>). Meta‐analyses of HR (with or without the inclusion of HR estimates we calculated from reported survival data) and IRR were essentially the same (<a href="./references#CD010709-fig-0012" title="">Analysis 1.6</a>; <a href="./references#CD010709-fig-0013" title="">Analysis 1.7</a>; <a href="./references#CD010709-fig-0014" title="">Analysis 1.8</a>; <a href="./references#CD010709-fig-0015" title="">Analysis 1.9</a>; <a href="./references#CD010709-fig-0016" title="">Analysis 1.10</a>). </p> </section> <section id="CD010709-sec-0069"> <h5 class="title">Unassisted patency (access thrombosis)</h5> <p>In the meta‐analysis of all studies (including people with a fistula or graft) we found that pre‐emptive correction of an AV access stenosis had modest but precise effect on the risk of potentially remediable failure (thrombosis) (<a href="./references#CD010709-fig-0017" title="">Analysis 1.11</a> (18 study comparisons, 1212 participants): RR 0.79, 95% CI 0.65 to 0.97; I² = 30%). There was moderate degree of heterogeneity in this meta‐analysis, which was largely explained by the modifying effect of access type. We found that pre‐emptive stenosis correction significantly reduced the risk of thrombosis in fistulas (<a href="./references#CD010709-fig-0018" title="">Analysis 1.12</a>.1 (7 study comparisons, 515 participants): RR 0.50, 95% CI 0.35 to 0.71; I² = 0%), but not in grafts (<a href="./references#CD010709-fig-0018" title="">Analysis 1.12</a>.2 (11 study comparisons, 697 participants): RR 0.95, 95% CI 0.80 to 1.12; I² = 0%). Subgroup analysis by prevention aim indicated that the effects of pre‐emptive stenosis correction may differ in studies of primary (<a href="./references#CD010709-fig-0019" title="">Analysis 1.13</a>.1 (13 study comparisons, 885 participants): RR 0.94, 95% CI 0.78 to 1.12; I² = 0%) and secondary prophylaxis (<a href="./references#CD010709-fig-0019" title="">Analysis 1.13</a>.2 (5 study comparisons, 327 participants): RR 0.53, 95% CI 0.32 to 0.87; I² = 59%), but there remained moderate residual heterogeneity across studies in this analysis. In subgroup analysis by prevention aim limited to studies in fistulas we found that pre‐emptive correction of stenosis had no effect on the risk of thrombosis in primary prophylaxis (<a href="./references#CD010709-fig-0020" title="">Analysis 1.14</a>.1 (4 study comparisons,316 participants): RR 0.75, 95% CI 0.42 to 1.36; I² = 0%) and significantly reduced the risk of thrombosis in studies of secondary prophylaxis (<a href="./references#CD010709-fig-0020" title="">Analysis 1.14</a>.2 (3 studies, 199 participants): RR 0.40, 95% CI 0.26 to 0.62; I² = 0%), with no residual heterogeneity across studies. However, the effect estimate in the secondary prophylaxis group was again derived from three studies (<a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a>; <a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). There were no significant subgroup differences in the risk of thrombosis by surveillance method in studies of primary prophylaxis (<a href="./references#CD010709-fig-0021" title="">Analysis 1.15</a>). Meta‐analyses of HR (with or without the inclusion of HR estimates we calculated from reported survival data) and IRR were essentially the same (<a href="./references#CD010709-fig-0022" title="">Analysis 1.16</a>; <a href="./references#CD010709-fig-0023" title="">Analysis 1.17</a>; <a href="./references#CD010709-fig-0024" title="">Analysis 1.18</a>; <a href="./references#CD010709-fig-0025" title="">Analysis 1.19</a>; <a href="./references#CD010709-fig-0026" title="">Analysis 1.20</a>; <a href="./references#CD010709-fig-0027" title="">Analysis 1.21</a>; <a href="./references#CD010709-fig-0028" title="">Analysis 1.22</a>; <a href="./references#CD010709-fig-0029" title="">Analysis 1.23</a>). </p> </section> <section id="CD010709-sec-0070"> <h5 class="title">Detection of stenosis and elective access repair</h5> <p>In <a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a>, access surveillance increased the probability of identification of fistula stenosis (<a href="./references#CD010709-fig-0030" title="">Analysis 1.24</a> (137 participants): RR 2.27, 95% CI 0.86 to 5.98). <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a> reported elective fistula repair was over five times as likely in the treatment group (<a href="./references#CD010709-fig-0031" title="">Analysis 1.25</a> (58 participants): RR 5.78, 95% CI 2.80 to 11.96). </p> </section> </section> <section id="CD010709-sec-0071"> <h4 class="title">Effects on health resource use and patient outcomes</h4> <section id="CD010709-sec-0072"> <h5 class="title">Resource use</h5> <p>We found that pre‐emptive correction of an AV access stenosis significantly increased the rates of diagnostic angiograms (<a href="./references#CD010709-fig-0032" title="">Analysis 1.26</a> (7 study comparisons, 539 participants): IRR 1.78, 95% CI 1.18 to 2.67; I² = 62%); has uncertain or imprecise effects on the rates of angioplasties or surgical procedures (<a href="./references#CD010709-fig-0033" title="">Analysis 1.27;</a><a href="./references#CD010709-fig-0034" title="">Analysis 1.28</a>; <a href="./references#CD010709-fig-0035" title="">Analysis 1.29</a>); and may reduce the rate of catheter use (<a href="./references#CD010709-fig-0036" title="">Analysis 1.30</a> (6 study comparisons, 394 participants): IRR 0.58, 95% CI 0.35 to 0.98; I² = 53%) or hospitalisation (<a href="./references#CD010709-fig-0037" title="">Analysis 1.31</a> (4 study comparisons, 219 participants): IRR 0.54, 95% CI 0.31 to 0.93; I² = 67%). Given the considerable heterogeneity in these analyses, effects on resource use are uncertain. We did not find data on resource and costs necessary to run a surveillance program. One study in secondary prophylaxis in people with fistulas did not find differences in costs between pre‐emptive and deferred correction of stenosis (<a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>). </p> </section> <section id="CD010709-sec-0073"> <h5 class="title">Patient outcomes</h5> <p>We found that pre‐emptive correction of an AV access stenosis may increase the rates of infection (<a href="./references#CD010709-fig-0038" title="">Analysis 1.32</a> (3 studies, 248 participants): IRR 1.74, 95% CI 0.78 to 3.91; I² = 0%) and mortality (<a href="./references#CD010709-fig-0039" title="">Analysis 1.33</a> (5 studies, 386 participants): RR 1.38, 95% CI 0.91 to 2.11; I² = 0%). We did not find data on surrogate outcomes and quality of life. </p> </section> </section> <section id="CD010709-sec-0074"> <h4 class="title">Other comparisons</h4> <p>Insufficient data were available to assess the effects of two surveillance methods versus one or to compare two different surveillance methods head‐to‐head (<a href="./references#CD010709-fig-0040" title="">Analysis 2.1</a>; <a href="./references#CD010709-fig-0041" title="">Analysis 2.2</a>; <a href="./references#CD010709-fig-0042" title="">Analysis 3.1</a>; <a href="./references#CD010709-fig-0043" title="">Analysis 3.2</a>; <a href="./references#CD010709-fig-0044" title="">Analysis 4.1</a>; <a href="./references#CD010709-fig-0045" title="">Analysis 4.2</a>; <a href="./references#CD010709-fig-0046" title="">Analysis 5.1</a>; <a href="./references#CD010709-fig-0047" title="">Analysis 5.2</a>; <a href="./references#CD010709-fig-0048" title="">Analysis 6.1</a>; <a href="./references#CD010709-fig-0049" title="">Analysis 6.2;</a><a href="./references#CD010709-fig-0050" title="">Analysis 7.1</a>; <a href="./references#CD010709-fig-0051" title="">Analysis 7.2</a>). </p> </section> <section id="CD010709-sec-0075"> <h4 class="title">Sensitivity analyses</h4> <p>Results were the same in several sensitivity analyses we conducted by including and excluding studies of two surveillance methods, studies in which venous pressure was measured in the intervention and/or in the comparator arm and studies in which clinical monitoring was or was not a co‐intervention. REML methods provided similar results as those based on the DL method, with the exception of the IRR diagnostic procedures, which was 1.64 (95% CI 1.24 to 2.18) (<a href="#CD010709-fig-0004">Figure 4</a>) versus 1.78 (1.18 to 2.67) we found using the DL method (<a href="./references#CD010709-fig-0032" title="">Analysis 1.26</a>). </p> <div class="figure" id="CD010709-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Sensitivity analyses using REML methods (Ravani 2016)" data-id="CD010709-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Sensitivity analyses using REML methods (<a href="./references#CD010709-bbs2-0086" title="RavaniP , QuinnRR , OliverMJ , KarsanjiDJ , JamesMT , MacRaeJM , et al. Preemptive correction of arteriovenous access stenosis: a systematic review and meta‐analysis of randomized controlled trials. American Journal of Kidney Diseases2016;ePub:in press. [http://dx.doi.org/10.1053/j.ajkd.2015.11.013] ">Ravani 2016</a>) </p> </div> </div> </div> </section> <section id="CD010709-sec-0076"> <h4 class="title">Small study effects</h4> <p>Funnel plots showed some evidence of asymmetry, suggesting the possible existence of small‐study effects or publication bias (<a href="#CD010709-fig-0005">Figure 5</a>; <a href="#CD010709-fig-0006">Figure 6</a>). However, the low number of studies did not permit further analyses. </p> <div class="figure" id="CD010709-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.2 Assisted patency: RR of access loss by access type." data-id="CD010709-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.2 Assisted patency: RR of access loss by access type. </p> </div> </div> </div> <div class="figure" id="CD010709-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.12 Unassisted patency: RR of access thrombosis by access type." data-id="CD010709-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.12 Unassisted patency: RR of access thrombosis by access type. </p> </div> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010709-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010709-sec-0077"></div> <p>In our systematic review we identified 14 studies (1390 participants) that reported the effects of pre‐emptive correction of AV access stenosis on access outcomes, health care resource use and patient outcomes. Nine studies assessed the effects of early identification of stenosis by means of access surveillance followed by its pre‐emptive correction (primary prophylaxis) and five assessed the effects of pre‐emptive correction of a known or suspected stenosis in an AV access (secondary prophylaxis). </p> <section id="CD010709-sec-0078"> <h3 class="title" id="CD010709-sec-0078">Summary of main results</h3> <p>In low‐ to moderate‐quality evidence from these studies, pre‐emptive correction of AV access stenosis decreases the risk of thrombosis in fistulas and probably increases the longevity of fistulas, but has little or no effect on the risk of thrombosis and the risk of loss of grafts. Pre‐emptive correction of access stenosis, however, may increase the rates of diagnostic procedures, has uncertain benefits in terms of avoidance of hospitalisation or catheters, and potential harms in terms of infection and mortality. On average, a strategy for pre‐emptive correction of stenosis in 1000 people using a fistula can prevent thrombosis in 200 (baseline risk = 0.4) and access loss in 50 (baseline risk = 0.1), but may require additional invasive procedures in 234 (baseline risk = 0.3). While available evidence does not support surveillance and pre‐emptive correction of graft stenosis, there is insufficient information about potential harms of access‐related procedures to support pre‐emptive correction of fistula stenosis. </p> </section> <section id="CD010709-sec-0079"> <h3 class="title" id="CD010709-sec-0079">Overall completeness and applicability of evidence</h3> <p>Considering that the effects of pre‐emptive correction of a stenosis on primary and secondary patency rates of grafts are close to unity, we believe that further research is unlikely to change our confidence that this intervention is not beneficial in grafts. Consistency of findings in several sensitivity and subgroup analyses further support this statement. </p> <p>Conversely, more data may be warranted for fistulas, considering that pre‐emptive correction of a stenosis reduces the risk of thrombosis and that there are potential benefits on assisted patency, although they are heavily influenced by three small studies from a single centre. More data are also necessary on the health resource use, including resources necessary to run a surveillance program, and patient‐centred outcomes, including quality of life, risk of infection and mortality. </p> </section> <section id="CD010709-sec-0080"> <h3 class="title" id="CD010709-sec-0080">Quality of the evidence</h3> <p>Overall the quality of available evidence is low to moderate. Most studies were at high risk of performance bias, although few showed that double blinding is possible in primary prophylaxis studies, and in most there was unclear risk of detection bias. Only one third of the studies were at low risk of selection bias. Because these forms of bias tend to inflate false positive results, we believe that additional RCTs of pre‐emptive stenosis correction are very unlikely to change the confidence in the size and direction we observed in grafts. Conversely, further studies would be informative to test whether potential benefits may exist in fistulas. </p> </section> <section id="CD010709-sec-0081"> <h3 class="title" id="CD010709-sec-0081">Potential biases in the review process</h3> <p>Although based on a peer‐reviewed protocol and conducted using methods developed by Cochrane, our review has limitations mostly related to the quality of the data on which the review is based. First, studies were few in number and small. Few were designed based on an explicit study question and none was powered to detect a meaningful effect. Second the overall quality of the studies was poor, as discussed above. Third most of the data were from grafts, a type of access used in &lt; 10% of the haemodialysis population in most countries, and little information is available for fistula, the access believed to be the optimal form of access for haemodialysis. Fourth, insufficient information was available on important factors that may impact outcomes, including algorithms for referral for intervention or intervention strategies (surgical versus radiological or other). Finally, resource use and patient outcomes such as infections and mortality were under‐reported and no information is available about cost of access surveillance programs and patient perspective or quality of life. </p> </section> <section id="CD010709-sec-0082"> <h3 class="title" id="CD010709-sec-0082">Agreements and disagreements with other studies or reviews</h3> <p>The findings of our systematic review are overall consistent with those by <a href="./references#CD010709-bbs2-0083" title="TonelliM , JamesM , WiebeN , JindalK , HemmelgarnB , Alberta Kidney Disease Network. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. American Journal of Kidney Diseases2008;51(4):630‐40. [MEDLINE: 18371539] ">Tonelli 2008</a>. Key differences include consideration of primary and secondary prophylaxis in our review; the addition of three studies (<a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a>; <a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a>; <a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a>); and analysis of patient outcomes. However, considering the high risk of access complications, and the morbidity burden and high cost associated with the effort to maintain a functioning AV access, the finding that only two studies were published since the publication of <a href="./references#CD010709-bbs2-0083" title="TonelliM , JamesM , WiebeN , JindalK , HemmelgarnB , Alberta Kidney Disease Network. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. American Journal of Kidney Diseases2008;51(4):630‐40. [MEDLINE: 18371539] ">Tonelli 2008</a> raises several concerns about the reasons and consequences of the falling interest in this topic, which is relevant to patients and the healthcare system. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010709-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study selection flow diagram‐PRISMA" data-id="CD010709-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study selection flow diagram‐PRISMA</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010709-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010709-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Sensitivity analyses using REML methods (Ravani 2016)" data-id="CD010709-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Sensitivity analyses using REML methods (<a href="./references#CD010709-bbs2-0086" title="RavaniP , QuinnRR , OliverMJ , KarsanjiDJ , JamesMT , MacRaeJM , et al. Preemptive correction of arteriovenous access stenosis: a systematic review and meta‐analysis of randomized controlled trials. American Journal of Kidney Diseases2016;ePub:in press. [http://dx.doi.org/10.1053/j.ajkd.2015.11.013] ">Ravani 2016</a>) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.2 Assisted patency: RR of access loss by access type." data-id="CD010709-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.2 Assisted patency: RR of access loss by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.12 Unassisted patency: RR of access thrombosis by access type." data-id="CD010709-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Pre‐emptive versus deferred correction, outcome: 1.12 Unassisted patency: RR of access thrombosis by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 1 Assisted patency: RR of access loss overall." data-id="CD010709-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 1 Assisted patency: RR of access loss overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 2 Assisted patency: RR of access loss by access type." data-id="CD010709-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 2 Assisted patency: RR of access loss by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 3 Assisted patency: RR of access loss by prevention aim." data-id="CD010709-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 3 Assisted patency: RR of access loss by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 4 Assisted patency: RR of fistula loss by prevention aim." data-id="CD010709-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 4 Assisted patency: RR of fistula loss by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 5 Assisted patency: RR of access loss by surveillance method (primary prophylaxis)." data-id="CD010709-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 5 Assisted patency: RR of access loss by surveillance method (primary prophylaxis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 6 Assisted patency: HR of access loss overall." data-id="CD010709-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 6 Assisted patency: HR of access loss overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 7 Assisted patency: HR of access loss by access type." data-id="CD010709-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 7 Assisted patency: HR of access loss by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 8 Assisted patency: HR of access loss by prevention aim." data-id="CD010709-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 8 Assisted patency: HR of access loss by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 9 Assisted patency: HR of access loss by surveillance method (primary prophylaxis)." data-id="CD010709-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 9 Assisted patency: HR of access loss by surveillance method (primary prophylaxis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 10 Assisted patency: IRR of access loss overall." data-id="CD010709-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 10 Assisted patency: IRR of access loss overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 11 Unassisted patency: RR of access thrombosis overall." data-id="CD010709-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 11 Unassisted patency: RR of access thrombosis overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-12.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 12 Unassisted patency: RR of access thrombosis by access type." data-id="CD010709-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 12 Unassisted patency: RR of access thrombosis by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 13 Unassisted patency: RR of access thrombosis by prevention aim." data-id="CD010709-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 13 Unassisted patency: RR of access thrombosis by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 14 Unassisted patency: RR of fistula thrombosis by prevention aim." data-id="CD010709-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 14 Unassisted patency: RR of fistula thrombosis by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 15 Unassisted patency: RR of access thrombosis by surveillance method (primary prophylaxis)." data-id="CD010709-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 15 Unassisted patency: RR of access thrombosis by surveillance method (primary prophylaxis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 16 Unassisted patency: HR of access thrombosis overall." data-id="CD010709-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 16 Unassisted patency: HR of access thrombosis overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 17 Unassisted patency: HR of access thrombosis by access type." data-id="CD010709-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 17 Unassisted patency: HR of access thrombosis by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 18 Unassisted patency: HR of access thrombosis by prevention aim." data-id="CD010709-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 18 Unassisted patency: HR of access thrombosis by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 19 Unassisted patency: HR of access thrombosis by surveillance method (primary prophylaxis)." data-id="CD010709-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 19 Unassisted patency: HR of access thrombosis by surveillance method (primary prophylaxis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 20 Unassisted patency: IRR of access thrombosis overall." data-id="CD010709-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 20 Unassisted patency: IRR of access thrombosis overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 21 Unassisted patency: IRR of access thrombosis by access type." data-id="CD010709-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 21 Unassisted patency: IRR of access thrombosis by access type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 22 Unassisted patency: IRR of access thrombosis by prevention aim." data-id="CD010709-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 22 Unassisted patency: IRR of access thrombosis by prevention aim. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 23 Unassisted patency: IRR of access thrombosis by surveillance method (primary prophylaxis)." data-id="CD010709-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 23 Unassisted patency: IRR of access thrombosis by surveillance method (primary prophylaxis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 24 Detection of access stenosis (HR)." data-id="CD010709-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 24 Detection of access stenosis (HR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 25 Elective stenosis repair." data-id="CD010709-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 25 Elective stenosis repair. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 26 Health resource use: angiograms (IRR)." data-id="CD010709-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 26 Health resource use: angiograms (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 27 Health resource use: angioplasties (IRR)." data-id="CD010709-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 27 Health resource use: angioplasties (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 28 Health resource use: surgical interventions (IRR)." data-id="CD010709-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 28 Health resource use: surgical interventions (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 29 Health resource use: radiological or surgical interventions (IRR)." data-id="CD010709-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 29 Health resource use: radiological or surgical interventions (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 30 Health resource use: use of catheters (IRR)." data-id="CD010709-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 30 Health resource use: use of catheters (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 31 Health resource use: hospitalizations (IRR)." data-id="CD010709-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 31 Health resource use: hospitalizations (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 32 Patient outcomes: infections (IRR)." data-id="CD010709-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 32 Patient outcomes: infections (IRR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pre‐emptive versus deferred correction, Outcome 33 Patient outcomes: mortality (RR)." data-id="CD010709-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Pre‐emptive versus deferred correction, Outcome 33 Patient outcomes: mortality (RR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Two surveillance methods versus one, Outcome 1 Access thrombosis (RR)." data-id="CD010709-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Two surveillance methods versus one, Outcome 1 Access thrombosis (RR).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Two surveillance methods versus one, Outcome 2 Health resource use: angioplasties (RR)." data-id="CD010709-fig-0041" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Two surveillance methods versus one, Outcome 2 Health resource use: angioplasties (RR). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Blood flow versus monitoring and venous pressure in grafts, Outcome 1 Assisted patency: RR of graft loss." data-id="CD010709-fig-0042" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Blood flow versus monitoring and venous pressure in grafts, Outcome 1 Assisted patency: RR of graft loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Blood flow versus monitoring and venous pressure in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis." data-id="CD010709-fig-0043" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Blood flow versus monitoring and venous pressure in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Blood flow and venous pressure vs monitoring and venous pressure in grafts, Outcome 1 Assisted patency: RR of graft loss." data-id="CD010709-fig-0044" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Blood flow and venous pressure vs monitoring and venous pressure in grafts, Outcome 1 Assisted patency: RR of graft loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Blood flow and venous pressure vs monitoring and venous pressure in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis." data-id="CD010709-fig-0045" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Blood flow and venous pressure vs monitoring and venous pressure in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Doppler versus monitoring alone in grafts, Outcome 1 Assisted patency: RR of graft loss." data-id="CD010709-fig-0046" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Doppler versus monitoring alone in grafts, Outcome 1 Assisted patency: RR of graft loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Doppler versus monitoring alone in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis." data-id="CD010709-fig-0047" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Doppler versus monitoring alone in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Doppler versus monitoring and venous pressure in grafts, Outcome 1 Assisted patency: RR of graft loss." data-id="CD010709-fig-0048" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Doppler versus monitoring and venous pressure in grafts, Outcome 1 Assisted patency: RR of graft loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Doppler versus monitoring and venous pressure in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis." data-id="CD010709-fig-0049" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Doppler versus monitoring and venous pressure in grafts, Outcome 2 Unassisted patency: RR of graft thrombosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Unassisted patency: RR of access thrombosis by use of venous pressure, Outcome 1 Fistulas." data-id="CD010709-fig-0050" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Unassisted patency: RR of access thrombosis by use of venous pressure, Outcome 1 Fistulas. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010709-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/urn:x-wiley:14651858:media:CD010709:CD010709-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_t/tCD010709-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Unassisted patency: RR of access thrombosis by use of venous pressure, Outcome 2 Grafts." data-id="CD010709-fig-0051" src="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Unassisted patency: RR of access thrombosis by use of venous pressure, Outcome 2 Grafts. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/media/CDSR/CD010709/image_n/nCD010709-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010709-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Scheduled surveillance versus clinical monitoring alone for preventing arteriovenous (AV) access failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Scheduled surveillance versus clinical monitoring alone for the prevention of AV access failure (maintenance of suitability for haemodialysis in an established AV access)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis. </p> <p>Settings: inpatient, outpatient or home care setting</p> <p>Intervention: Surveillance of the access with Doppler ultrasound or blood flow measurements with or without clinical monitoring of the access. </p> <p>Comparison: clinical monitoring alone, i.e. physical examination with or without haemodynamic parameters measured during haemodialysis (e.g. pump blood flow, arterial and venous pressure) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Monitoring alone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Surveillance in addition to monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Risk of access thrombosis</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Higher risk population (people using a graft for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR</b> 0.95 (0.8, 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>697 (11 cohorts from 8 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Most studies are small with low‐quality reporting</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>475 per 1000</b> <br/> (400 to 560) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Lower risk population (people using a fistula for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 0.5 (0.35, 0.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>515 (7 cohorts from 6 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>400 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/> (140 to 284) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Rate of angiograms</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>People using any AV access (fistula or graft)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 1.78 (1.18, 2.67) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>539 (7 cohorts from 5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>300 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>534 per 1000</b> </p> <p>(354 to 801)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Baseline risks and rates (among controls ‐ people receiving clinical monitoring without surveillance) were calculated from the survival plots or information the papers reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Scheduled surveillance versus clinical monitoring alone for preventing arteriovenous (AV) access failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010709-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Scheduled surveillance versus clinical monitoring alone for the prevention of arteriovenous (AV) access failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Scheduled surveillance versus clinical monitoring alone for the prevention of AV access failure (maintenance of suitability for haemodialysis in an established AV access)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis. </p> <p>Settings: inpatient, outpatient or home care setting.</p> <p>Intervention: Surveillance of the access with Doppler ultrasound or blood flow measurements with or without clinical monitoring of the access. </p> <p>Comparison: clinical monitoring alone, i.e. physical examination with or without haemodynamic parameters measured during haemodialysis (e.g. pump blood flow, arterial and venous pressure) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Monitoring alone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Surveillance in addition to monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Risk of access loss</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Higher risk population (people using a graft for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR</b> 0.90 (0.71, 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>662 (7 cohorts from 6 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Most studies are small with low‐quality reporting</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>135 per 1000</b> <br/> (107 to 172) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Lower risk population (people using a fistula for haemodialysis)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 0.5 (0.29, 0.86) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>310 (4 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (29 to 86) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Mortality</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>People using any AV access (fistula or graft)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR</b> 1.38 (0.90, 2.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>586 (5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>207 per 1000</b> </p> <p>(135 to 317)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Baseline risks and rates (among controls ‐ people receiving clinical monitoring without surveillance) were calculated from the survival plots or information the papers reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Scheduled surveillance versus clinical monitoring alone for the prevention of arteriovenous (AV) access failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010709-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Format of reported outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Loss</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Thrombosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Angiography</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> PTA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> SX</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> PTA or SX</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Need for CVC</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Infection</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Hospital admission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Stenosis detection</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Death</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0001" title="DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous (AV) graft stenosis [abstract no: SU‐PO644]. Journal of the American Society of Nephrology2002;13(September):232A. [CENTRAL: CN‐00445068] DemberLM , HolmbergEF , KaufmanJS . Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International2004;66(1):390‐8. [MEDLINE: 15200448] ">Dember 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0002" title="LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Cost efficacy of duplex surveillance and prophylactic angioplasty of arteriovenous ePTFE grafts. Annals of Vascular Surgery1998;12(2):138‐42. [MEDLINE: 9514231] LumsdenAB , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , MartinLG . Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. Journal of Vascular Surgery1997;26(3):382‐90. [MEDLINE: 9308584] MartinLG , MacDonalMJ , KikeriD , HarkerLA , LumsdenAB . Prospectively randomized trial to evaluate PTA for treatment of PTFE dialysis graft stenosis: early 622 day (mean, 367 day) results [abstract]. American Journal of Roentgenology1996;166(3):53. [CENTRAL: CN‐00307667] MartinLG , MacDonaldMJ , KikeriD , CotsonisGA , HarkerLA , LumsdenAB . Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. Journal of Vascular &amp; Interventional Radiology1999;10(4):389‐96. [MEDLINE: 10229464] ">Lumsden 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR†; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0003" title="MalikJ , SlavikovaM , SvobodovaJ , TukaV . Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney International2005;67(4):1554‐8. [MEDLINE: 15780111] ">Malik 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR^</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0004" title="MayerDA , ZingaleRG , TsapogasMJ . Duplex scanning of expanded polytetrafluoroethylene dialysis shunts: Impact on patient management and graft survival. Vascular and Endovascular Surgery1993;27(9):647‐58. [EMBASE: 1993357035] ">Mayer 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0005" title="MoistLM , ChurchillDN , HouseAA , MillwardSF , ElliottJE , KribsSW , et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. Journal of the American Society of Nephrology2003;14(10):2645‐53. [MEDLINE: 14514744] MoistLM , LindsayRM , HouseAA , StittLW , ElliottJA , KribsSW , et al. Does the regular monitoring of access blood flow rate (QA) improve the survival of AV grafts? Results of a randomized clinical trial [abstract no: SA‐FC166]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00446800] ">Moist 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0006" title="PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Does monthly native arteriovenous fistula blood‐flow surveillance detect significant stenosis—a randomized controlled trial. Nephrology Dialysis Transplantation2006;21(9):2498–506. [MEDLINE: 16854848] PolkinghorneKR , LauKK , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: P77]. Nephrology2004;9(1):A20. [CENTRAL: CN‐00509421] PolkinghorneKR , LauKP , SaunderA , AtkinsRC , KerrPG . Native arteriovenous fistula blood flow surveillance: a randomised controlled trial [abstract no: SU‐FC078]. Journal of the American Society of Nephrology2004;15(Oct):60A. ">Polkinghorne 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0007" title="DossabhoyNR , RamSJ , NassarR , WorkJ , EasonJM , PaulsonWD . Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Seminars in Dialysis2005;18(6):550‐7. [MEDLINE: 16398720] DossabhoyNR , RamSJ , WorkJ , SwamyS , PaulsonWD . Influence of hemodialysis graft stenosis and blood flow surveillance on hospitalization and catheterization rates: a randomized controlled trial [abstract]. Journal of the American Society of Nephrology2003;14(Nov):54A. [CENTRAL: CN‐00550657] KrivitskiN , GantelaS , KislukhinV . Inadequate group size compromises conclusions of hemodialysis graft surveillance study. Kidney International2004;65(4):1520‐1. [MEDLINE: 15086500] RamSJ , WorkJ , CalditoGC , EasonJM , PervezA , PaulsonWD . A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International2003;64(1):272‐80. [MEDLINE: 12787419] RamSJ , WorkJ , EasonJM , CalditoGC , PaulsonWD . A prospective randomized controlled trial comparing stenosis and blood flow (QA) surveillance followed by intervention in hemodialysis grafts [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):300A. [CENTRAL: CN‐00447335] ">Ram 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR†;HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0010" title="RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized clinical trial comparison on ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes [abstract no: TH‐FC043]. Journal of the American Society of Nephrology2005;16:10A. [CENTRAL: CN‐00583233] RobbinML , OserRF , LeeJY , HeudebertGR , MennemeyerST , AllonM . Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney International2006;69(4):730‐5. [MEDLINE: 16518328] ">Robbin 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0011" title="SandsJJ , JabyacPA , MirandaCL , KapsickBJ . Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO Journal1999;45(3):147‐50. [MEDLINE: 10360713] SandsJJ , KapsickB , JabyacP . Monthly access flow monitoring decreases thrombosis in PTFE grafts but not in AV fistulas [abstract no: A0938]. Journal of the American Society of Nephrology1998;9:183A. ">Sands 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0016" title="ScaffaroLA , BettioJA , CavazzolaSA , CamposBT , BurmeisterJE , PereiraRM , et al. Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. Journal of Ultrasound in Medicine2009;28(9):1159‐65. [MEDLINE: 19710213] ">Scaffaro 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0017" title="SmitsJH , LindenJ , HagenEC , Modderkolk‐CammeraatEC , FeithGW , KoomansHA , et al. Graft surveillance: venous pressure, access flow, or the combination?. Kidney International2001;59(4):1551‐8. [MEDLINE: 11260420] SmitsJH , van derLindenJ , Van denDorpelMA , BlankestijnPJ . Graft surveillance: venous pressure, access flow, or the combination? [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):218A. ">Smits 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR; HR‡</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0020" title="TessitoreN , BedognaV , MansuetoG , GammaroL , MoranaG , LipariG , et al. Angioplasty (PTA) of subclinical stenoses and survival of native arteriovenous fistula (AVF) for haemodialysis: a prospective randomized study [abstract no: O46]. Nephrology Dialysis Transplantation2002;17(Suppl 12):15. [CENTRAL: CN‐00782198] TessitoreN , MansuetoG , BedognaV , LipariG , PoliA , GammaroL , et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. Journal of the American Society of Nephrology2003;14(6):1623‐7. [MEDLINE: 12761264] ">Tessitore 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR; RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0021" title="TessitoreN , LipariG , MansuetoG , BedognaV , BaggioE , GammaroL , et al. Prospective randomized trial of effect of pre‐emptive correction of stenosis on arteriovenous fistula (AVF) survival [abstract no: SA‐FC164]. Journal of the American Society of Nephrology2002;13(September):34A. [CENTRAL: CN‐00447980] TessitoreN , LipariG , PoliA , BedognaV , BaggioE , LoschiavoC , et al. Can blood flow surveillance and pre‐emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrology Dialysis Transplantation2004;19(9):2325‐33. [MEDLINE: 15280529] ">Tessitore 2004a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010709-bbs2-0022" title="TessitoreN , BedognaV , PoliA , LipariG , PertileP , BaggioE , et al. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrology Dialysis Transplantation2014;29(1):179‐87. [MEDLINE: 24166470] ">Tessitore 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR; HR; IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IRR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="12"> <div class="table-footnote"> <p>PTA indicates angioplasty; SX ‐ surgical intervention; CVC ‐ central venous catheter; RR ‐ relative risk; HR ‐ hazard ratio (time to event data); IRR ‐ incidence rate ratio (from rate data). </p> <p>^Rates and follow‐up reported</p> <p>†Events from survival plots</p> <p>‡Log‐HR (and their standard errors) were not reported by the authors but were estimated from survival plots (or tables) using the methods proposed by <a href="./references#CD010709-bbs2-0077" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints.[Erratum appears in Stat Med. 2004 Jun 15;23(11):1817]. Statistics in Medicine1998;17(24):2815–34. [MEDLINE: 9921604] ">Parmar 1998</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Format of reported outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/full#CD010709-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Pre‐emptive versus deferred correction</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Assisted patency: RR of access loss overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>972</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.64, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Assisted patency: RR of access loss by access type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>972</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.64, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Fistula</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.29, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>662</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.69, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Assisted patency: RR of access loss by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>972</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.64, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.63, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.49, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Assisted patency: RR of fistula loss by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.29, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.15, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.28, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Assisted patency: RR of access loss by surveillance method (primary prophylaxis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.63, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Doppler ultrasound (access flow and structure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.59, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Blood flow (access flow only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.52, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Assisted patency: HR of access loss overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>729</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.39, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Assisted patency: HR of access loss by access type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>729</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.39, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Fistula</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.16, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>592</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.44, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Assisted patency: HR of access loss by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>729</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.39, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>528</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.38, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.18, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Assisted patency: HR of access loss by surveillance method (primary prophylaxis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>528</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.38, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Doppler ultrasound (access flow and structure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.25, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Blood flow (access flow only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.39, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Assisted patency: IRR of access loss overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.22, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Unassisted patency: RR of access thrombosis overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.65, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Unassisted patency: RR of access thrombosis by access type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.65, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Fistula</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.35, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Unassisted patency: RR of access thrombosis by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.65, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.32, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Unassisted patency: RR of fistula thrombosis by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.35, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.42, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.26, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Unassisted patency: RR of access thrombosis by surveillance method (primary prophylaxis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Doppler ultrasound (access flow and structure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.65, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Blood flow (access flow only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.83, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Static venous pressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.17, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Unassisted patency: HR of access thrombosis overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>861</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.51, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Unassisted patency: HR of access thrombosis by access type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>861</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.51, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Fistula</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.16, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>662</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.73, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Unassisted patency: HR of access thrombosis by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>861</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.51, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>534</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.75, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.27, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Unassisted patency: HR of access thrombosis by surveillance method (primary prophylaxis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>534</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.75, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Doppler ultrasound (access flow and structure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.62, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 Blood flow (access flow only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.58, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Unassisted patency: IRR of access thrombosis overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.39, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Unassisted patency: IRR of access thrombosis by access type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.39, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Fistula</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.15, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 Graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Unassisted patency: IRR of access thrombosis by prevention aim <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.39, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Primary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Secondary prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.15, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Unassisted patency: IRR of access thrombosis by surveillance method (primary prophylaxis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Doppler ultrasound (access flow and structure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.40, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Blood flow (access flow only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.68, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Detection of access stenosis (HR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Elective stenosis repair <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Health resource use: angiograms (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [1.18, 2.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Health resource use: angioplasties (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>815</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.87, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Health resource use: surgical interventions (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.62, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Health resource use: radiological or surgical interventions (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>585</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.80, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Health resource use: use of catheters (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.35, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Health resource use: hospitalizations (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.31, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Patient outcomes: infections (IRR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [0.78, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Patient outcomes: mortality (RR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.91, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Pre‐emptive versus deferred correction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Two surveillance methods versus one</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Access thrombosis (RR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.28, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 All studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.19, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Ultrasound and static venous pressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.17, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Ultrasound and access flow</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.08, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Grafts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.19, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Fistulas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.06, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Health resource use: angioplasties (RR) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.36, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Two surveillance methods versus one</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Blood flow versus monitoring and venous pressure in grafts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Assisted patency: RR of graft loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.38, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Unassisted patency: RR of graft thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.64, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Blood flow versus monitoring and venous pressure in grafts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Blood flow and venous pressure vs monitoring and venous pressure in grafts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Assisted patency: RR of graft loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.42, 2.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Unassisted patency: RR of graft thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.85, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Blood flow and venous pressure vs monitoring and venous pressure in grafts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Doppler versus monitoring alone in grafts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Assisted patency: RR of graft loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.69, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Unassisted patency: RR of graft thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.48, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Doppler versus monitoring alone in grafts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Doppler versus monitoring and venous pressure in grafts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Assisted patency: RR of graft loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.36, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Unassisted patency: RR of graft thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.70, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Doppler versus monitoring and venous pressure in grafts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010709-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Unassisted patency: RR of access thrombosis by use of venous pressure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Fistulas <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.23, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 No VP measurement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.23, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 VP included</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.03, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Grafts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>633</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.81, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 No VP measurement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.61, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 VP included</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Unassisted patency: RR of access thrombosis by use of venous pressure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010709.pub2/references#CD010709-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010709.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010709-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010709-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="pt#CD010709-note-0001">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010709\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010709\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010709\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010709\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010709\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010709.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010709.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010709.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010709.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010709.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724728732"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010709.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724728736"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010709.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e69eacfd71c00',t:'MTc0MDcyNDcyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 